Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,49961,-0.0643823011514817,0.0212799613157535,-0.106091025330359,-0.0226735769726049,0.00248534635601497
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,47834,-0.0616196323906421,0.0236004777904889,-0.10787656886,-0.0153626959212839,0.00903637747055762
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1070.Time spent watching television (TV),51155,-0.0344890709787308,0.0218782287721363,-0.0773703993721179,0.00839225741465632,0.114945619695907
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1080.Time spent using computer,47912,-0.0436126485929239,0.0212881540325512,-0.0853374304967243,-0.00188786668912345,0.0405071792899957
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1090.Time spent driving,43744,-0.0723277548309557,0.0243690399308286,-0.12009107309538,-0.0245644365665316,0.0030021458524123
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1160.Sleep duration,51941,0.0564095363272743,0.0191022810065982,0.0189690655543418,0.0938500071002068,0.00314996942158984
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35545,0.00930085643882793,0.0266938948982731,-0.0430191775617873,0.0616208904394432,0.727531563213387
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35545,-0.0324958653080787,0.0256387338579399,-0.0827477836696408,0.0177560530534834,0.205040174444567
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35545,0.0157381105801184,0.0280416440760066,-0.0392235118088545,0.0706997329690912,0.574653295677011
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35545,0.0226951375509364,0.0281548806256997,-0.032488428475435,0.0778787035773079,0.420225851387316
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35545,0.074756786141453,0.0283173240441548,0.0192548310149095,0.130258741267996,0.00831169504526983
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35545,-0.0361369690144788,0.0719442468736122,-0.177147692886759,0.104873754857801,0.61548004506143
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35545,-0.068739489577245,0.0743417738042273,-0.21444936623353,0.0769703870790405,0.355187546130057
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35545,0.00664908541965729,0.0478611695320209,-0.0871588068631037,0.100456977702418,0.889514275107084
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35545,0.0412449891249798,0.0349562391376645,-0.0272692395848426,0.109759217834802,0.238082788042928
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35545,-0.0307671616521123,0.0229208840556919,-0.0756920944012684,0.0141577710970437,0.179540232908133
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35545,-0.0161142165293185,0.0345298987258102,-0.0837928180319064,0.0515643849732694,0.640748922649776
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35545,0.0160509294678204,0.0185217960314911,-0.0202517907539021,0.052353649689543,0.386195696377143
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35545,-0.0120391797712957,0.0242284630823618,-0.0595269674127248,0.0354486078701334,0.6192751275622
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35545,-0.0496044430224001,0.0343238275839876,-0.116879145087016,0.0176702590422157,0.148453938628925
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35545,-0.0340218008375251,0.0323817658305025,-0.09749006186531,0.0294464601902598,0.293460782618548
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35545,-0.0282294996367834,0.0498249695902562,-0.125886440033686,0.0694274407601188,0.571024110281333
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35545,-0.0893991089288823,0.047079488899441,-0.181674907171787,0.00287668931402207,0.0576232719237605
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35545,0.0127128059988973,0.0251522797395863,-0.0365856622906919,0.0620112742884865,0.613271900350773
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35545,0.0137567126999004,0.0237658870888057,-0.0328244259941587,0.0603378513939596,0.562715773992335
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35545,-0.0175392833062847,0.0302908080281646,-0.0769092670414874,0.0418307004289179,0.562589538562999
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,35549,0.0838331308193271,0.0379645103161141,0.00942269059974349,0.158243571038911,0.0272661044554028
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35547,0.0353514330931007,0.03779864839334,-0.0387339177578457,0.109436783944047,0.349691665660421
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35549,0.0475808127544896,0.0401443919687406,-0.031102195504242,0.126263821013221,0.235966176273926
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120098.Mobility problems today,35553,0.0965419865560646,0.0414911011992284,0.0152194282055769,0.177864544906552,0.0200065450464641
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120099.Self-care problems today,35553,-0.00704983707307294,0.0638842606558792,-0.132262987958596,0.11816331381245,0.912132695798672
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120100.Problems doing usual activities,35553,0.102941045543735,0.0405929715687927,0.0233788212689012,0.182503269818569,0.0112385735023484
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120101.Pain or discomfort today,35553,0.0100918780098872,0.0378599600439041,-0.0641136436761648,0.0842973996959392,0.789818087327014
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120102.Anxiety or depression today,35553,-0.00282567098327885,0.0474234332062181,-0.0957756000674663,0.0901242581009086,0.952488950304496
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,35532,-0.0177621752731931,0.0080749583010132,-0.0335890935431789,-0.00193525700320719,0.0278668909301493
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35528,0.00476824336330276,0.0487913246526236,-0.0908627529558394,0.100399239682445,0.922151947422621
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35519,0.0102113090559992,0.0504495322622418,-0.0886697741779947,0.109092392289993,0.839605524306742
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35534,-0.0229913337219443,0.0380475893768936,-0.0975646089006557,0.0515819414567672,0.545680241171728
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35533,0.0645794368963806,0.0391170903400897,-0.0120900601701952,0.141248933962956,0.0988031577079039
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35544,0.0499540020873757,0.0558251779057558,-0.0594633466079056,0.159371350782657,0.370912298189728
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35524,-0.0365274707750253,0.0543744595225926,-0.143101411439307,0.0700464698892562,0.501750671077238
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35537,0.123497311515423,0.0544268618162183,0.016820662355635,0.230173960675211,0.0232986926017983
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35536,0.0413061275082195,0.0753674372826869,-0.106414049565847,0.189026304582286,0.583667724386109
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35516,-0.0824594212957056,0.113650349196258,-0.305214105720371,0.14029526312896,0.468139332560918
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33408,0.0298178491894903,0.0536159628996606,-0.0752694380938445,0.134905136472825,0.578146381940433
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50152,0.0117363830583645,0.0474932564834509,-0.0813503996491992,0.104823165765928,0.804820228643325
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48372,-0.0225313455453622,0.029361399396793,-0.0800796883630765,0.0350169972723521,0.442865167491137
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51492,-0.026918701545572,0.0200722151245846,-0.0662602431897577,0.0124228400986137,0.179904011822445
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50699,-0.0266968898685589,0.0210026913673611,-0.0678621649485868,0.0144683852114689,0.203700577411168
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51412,0.0408778514405167,0.0206591658987366,0.000385886278992942,0.0813698166020405,0.0478645226304535
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,50223,0.0694132623426166,0.0206599209563033,0.0289198172682622,0.109906707416971,0.00078136741962014
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52148,0.0520688644844803,0.0319493938535773,-0.0105519474685312,0.114689676437492,0.103172437121486
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52149,0.141891234471661,0.0207975683493668,0.101128000506902,0.18265446843642,9.17003870151547e-12
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52149,0.0163765289976146,0.020043195768298,-0.0229081347082494,0.0556611927034787,0.413901609364307
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52149,0.175787492708536,0.0200092304232977,0.136569401078872,0.215005584338199,1.66625152111191e-18
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1438.Bread intake,51532,0.0220975438449384,0.00462184071375037,0.0130387360459877,0.0311563516438891,1.7543713447549e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1458.Cereal intake,51179,0.0930583946549926,0.019716888622695,0.0544132929545104,0.131703496355475,2.37611450630607e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1488.Tea intake,51448,0.0163393773419556,0.0044879162308983,0.00754306152939497,0.0251356931545163,0.000272461975647483
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1498.Coffee intake,50478,0.0401865922751936,0.0198404729317201,0.00129926532902219,0.079073919221365,0.0428299794288304
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1528.Water intake,50287,0.020673291997532,0.0199859624600208,-0.0184991944241087,0.0598457784191727,0.300965449569819
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,44861,-0.108008797729119,0.0232227505160513,-0.15352538874058,-0.0624922067176588,3.33043724460456e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44857,-0.0979269404819445,0.0237692776959022,-0.144514724765913,-0.0513391561979763,3.80992316256988e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44904,-0.134246641755946,0.0269777243090364,-0.187122981401658,-0.0813703021102351,6.55295376797571e-07
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,44841,-0.101138633262581,0.0250772230383131,-0.150289990417675,-0.0519872761074875,5.53099786159418e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,44891,0.074852127765106,0.0376464933746682,0.0010650007507563,0.148639254779456,0.0467970198187613
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45879,0.0708006927779501,0.0242095514466346,0.0233499719425463,0.118251413613354,0.00345480722568226
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1807.Father's age at death,50042,0.00554514019189539,0.00431895656829565,-0.00292001468196409,0.0140102950657549,0.199188634923831
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1845.Mother's age,32578,0.041999657115798,0.0203955084745671,0.00202446050564637,0.0819748537259495,0.0395456745220086
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1873.Number of full brothers,51731,0.012510392604107,0.0190794396035879,-0.0248853090189253,0.0499060942271394,0.512023725707975
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1883.Number of full sisters,51738,0.00986821669892872,0.0192613554384321,-0.0278840399603982,0.0476204733582556,0.608423403811612
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20015.Sitting height,51982,-0.0178257548835063,0.00577087092730016,-0.0291366619010146,-0.00651484786599802,0.00201127581714548
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36688,0.0164069988525005,0.0305445660552989,-0.0434603506158853,0.0762743483208862,0.591180313437775
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20018.Prospective memory result,37047,0.0710402708939173,0.0379251266633946,-0.00329297736633616,0.145373519154171,0.0610818117897514
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36566,0.0160186900731397,0.00795833452013824,0.000420354413668739,0.0316170257326106,0.0441699226311541
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36554,0.02457450842668,0.0079757733521772,0.00894199265641271,0.0402070241969473,0.00206968077333445
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51845,0.00801114765500152,0.00472332520722657,-0.00124656975116257,0.0172688650611656,0.089884061768802
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48753,-0.00477411509372449,0.00981940013756711,-0.024020139363356,0.014471909175907,0.626836395919218
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48308,0.00352073698385323,0.0209679706196642,-0.0375764854306886,0.0446179593983951,0.866655670433052
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48275,0.0126785174330568,0.0279181743472737,-0.0420411042875996,0.0673981391537131,0.649739475604136
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48284,0.0146462492032904,0.0267552208437829,-0.037793983650524,0.0670864820571049,0.584099025358134
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48307,-0.00227978435501306,0.0185027645120668,-0.0385452027986639,0.0339856340886378,0.901939588760667
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48477,0.00614859821158442,0.0123407429285075,-0.0180392579282903,0.0303364543514592,0.618323632411618
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48423,-0.0282896916419579,0.0151034702108012,-0.0578924932551282,0.00131310997121239,0.0610753895084496
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48326,-0.0157220470107565,0.0195089742197791,-0.0539596364815234,0.0225155424600104,0.420317482848834
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48476,-0.0111296433261398,0.013324208679263,-0.0372450923374953,0.0149858056852157,0.403562047466099
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48463,0.0028781657723425,0.0123618642986741,-0.0213510882530587,0.0271074197977437,0.815898847530536
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48349,0.040597347772169,0.0176598089829211,0.00598412216564371,0.0752105733786942,0.0215238618395063
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49847,0.0143543403592685,0.0107178071921502,-0.00665256173734601,0.035361242455883,0.180488338364249
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49686,-0.0296891428947451,0.0140054419393407,-0.0571398090958529,-0.00223847669363728,0.0340324495726149
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49598,-0.0227078930119277,0.0310589149173403,-0.0835833662499148,0.0381675802260594,0.46471230533217
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49624,0.00528788015203202,0.0193968114321969,-0.0327298702550739,0.043305630559138,0.785151206026297
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49780,0.0182445428625861,0.0117437588280648,-0.00477322444042089,0.0412623101655931,0.120306631005284
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49641,-0.0458034464653803,0.0226441846824816,-0.0901860484430442,-0.00142084448771633,0.043112274260104
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49630,-0.0125788468843721,0.0190047884144,-0.0498282321765961,0.0246705384078518,0.508057025656224
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49633,-0.0235110341802047,0.0168221365174089,-0.0564824217543262,0.00946035339391681,0.162240953961669
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49679,0.0030675396708758,0.0187851779906501,-0.0337514091907984,0.03988648853255,0.87028719327908
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49824,0.00441331708070569,0.0104444652383553,-0.0160578347864707,0.0248844689478821,0.672627437625029
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49691,0.0299535564162342,0.0160139047480509,-0.0014336968899456,0.0613408097224139,0.0614325764002831
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46057,0.00794378299907589,0.013460708226436,-0.0184392051247387,0.0343267711228905,0.555100685066947
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45882,0.00425918867141407,0.0467657446066837,-0.087401670757686,0.0959200481005141,0.927434116077291
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45872,0.0385605806840835,0.0498859055827583,-0.0592157942581227,0.13633695562629,0.439547860022842
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45905,0.00963515172799079,0.0205469088608388,-0.0306367896392532,0.0499070930952347,0.639122666635998
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45899,0.0236018673449778,0.0277932623625252,-0.0308729268855715,0.0780766615755271,0.395785606376564
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45934,0.0232112540825577,0.0223727603930325,-0.020639356287786,0.0670618644529014,0.299527975407392
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45895,-0.0328281679895549,0.0249926088360535,-0.0818136813082198,0.01615734532911,0.189027495099207
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45889,0.00459177642336716,0.0252908047347157,-0.0449782008566757,0.05416175370341,0.855930931854525
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45912,0.0146316596662735,0.0205587797704656,-0.025663548683839,0.054926868016386,0.476661218122581
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45926,-0.0179511059251128,0.0244070539684209,-0.0657889317032177,0.0298867198529921,0.462052389977655
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46100,0.00126139613692624,0.011328766466151,-0.0209429861367297,0.0234657784105822,0.911344469725389
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45992,0.0387568147616213,0.0155565151034171,0.00826604515892388,0.0692475843643187,0.012735233095423
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20127.Neuroticism score,47207,0.018084100189459,0.0199989793414161,-0.0211138993197167,0.0572820996986346,0.365874340524033
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36688,0.0256913966087144,0.0311292030903435,-0.0353218414483588,0.0867046346657876,0.409219117119657
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,36961,0.00603515939497017,0.0075236034805276,-0.00871110342686393,0.0207814222168043,0.422482980124399
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36961,0.00581732007183418,0.00777192736049898,-0.00941565755474382,0.0210502976984122,0.454178769829981
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34303,0.0392370719558679,0.0389105324533073,-0.0370275716526144,0.11550171556435,0.313314150942621
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34304,-0.0225956079781307,0.0396082840096168,-0.10022784463698,0.0550366286807182,0.56837948012184
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33666,-0.0784446080858643,0.0428664868493203,-0.162462922310532,0.00557370613880348,0.0673202964951069
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20255.Spirometry QC measure,46134,0.0241420240623783,0.0253922852264459,-0.0256268549814556,0.0739109031062122,0.341738685964845
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20261.avMSE,34300,-0.013598743563525,0.00897235188072999,-0.0311845532497558,0.00398706612270574,0.12967546133975
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20262.Myopia diagnosis,34300,0.128490958716079,0.048823996448691,0.0327959256766445,0.224185991755513,0.00852100737185857
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,42461,-0.00776466676719587,0.00578618895612544,-0.0191055971212017,0.00357626358680999,0.179641310213436
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42489,0.0372235733961085,0.00592269693861134,0.0256150873964303,0.0488320593957868,3.3830340712448e-10
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36358,0.0431018689819445,0.0369094229360192,-0.0292405999726533,0.115444337936542,0.242936751852229
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36358,-0.00819463522768853,0.0689298300893767,-0.143297102202867,0.12690783174749,0.90537080608665
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36359,-0.0566591301392439,0.11607968251804,-0.284175307874602,0.170857047596114,0.625490059915982
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36359,0.0309744153683945,0.0338250128691899,-0.0353226098552177,0.0972714405920068,0.359841882325736
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36359,-0.103937941246813,0.0698812018987949,-0.240905096968451,0.0330292144748252,0.136965887109357
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36362,-0.0920974516337592,0.088691176035359,-0.265932156663063,0.0817372533955445,0.299116091488623
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36362,0.0187690513082731,0.0547078801893575,-0.0884583938628677,0.125996496479414,0.731550100789259
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36362,-0.0366731982304344,0.0654071899350993,-0.164871290503229,0.0915248940423602,0.575025983681441
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36362,0.0253747032704158,0.102568618662536,-0.175659789308155,0.226409195848987,0.804611591521818
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36362,-0.144536791884599,0.119848971117828,-0.379440775275542,0.0903671915063444,0.227860728942159
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36362,0.0130424301895522,0.0728777525898482,-0.12979796488655,0.155882825265655,0.857971715823181
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36362,-0.197429465546034,0.128668231348475,-0.449619198989046,0.0547602678969771,0.124973632100174
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36362,-0.0851261741951772,0.0856987637823183,-0.253095751208521,0.0828434028181667,0.320588256253359
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36361,-0.0956036971316441,0.116026542728273,-0.323015720879059,0.131808326615771,0.40997762390839
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36361,0.0296870963430111,0.0457318648186881,-0.0599473587016175,0.11932155138764,0.516258605528343
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36361,0.0330441440775217,0.0836169832058557,-0.130845143005956,0.196933431160999,0.692718417956212
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36363,0.261645016081441,0.146805305930629,-0.0260933835425922,0.549383415705474,0.0747493842189333
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36181,-0.104293915040973,0.0333372942789035,-0.169635011827624,-0.0389528182543223,0.00176457295441362
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36181,0.0478991026836562,0.0331210009295974,-0.0170180591383546,0.112816264505667,0.148170165070768
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36181,-0.00320934092088095,0.0331552110207299,-0.0681935545215115,0.0617748726797496,0.922890003971782
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20603.Liking for apples,36181,0.014849234001835,0.0340585324002652,-0.0519054895026848,0.0816039575063548,0.662856311969722
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36181,-0.0235976263962664,0.0336677788074994,-0.0895864728589653,0.0423912200664325,0.483391015206997
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36181,-0.0460163896638447,0.0330662402621143,-0.110826220577589,0.0187934412498993,0.164075000254566
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36181,-0.0480487758842944,0.0334265735192002,-0.113564859981927,0.017467308213338,0.15063715165698
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36181,0.00715870635294055,0.0334098961942131,-0.0583246901877171,0.0726421028935982,0.830343521329145
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36181,-0.00967362378103706,0.0341048325429613,-0.0765190955652412,0.0571718480031671,0.776691794081063
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36181,0.025770192070383,0.0345827215390549,-0.0420119421461646,0.0935523262869306,0.456190811987392
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36181,-0.00642317975616285,0.0333407846166425,-0.0717711176047822,0.0589247580924565,0.847236867475496
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36181,-0.0077579223058568,0.0336729213494173,-0.0737568481507146,0.058241003539001,0.817795070373178
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36181,0.0153817053600415,0.033658153999865,-0.0505882764796939,0.0813516871997768,0.6476867878268
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36181,-0.0416901000925935,0.033237119245784,-0.10683485381433,0.0234546536291431,0.209766455766205
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36181,0.00151317917042202,0.0328837798406663,-0.0629390293172839,0.065965387658128,0.96329883445474
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36181,0.088830717100643,0.0335051984042396,0.0231605282283334,0.154500905972953,0.00803752191482061
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36181,-0.00895058984965644,0.0334430936595262,-0.0744990534223278,0.056597873723015,0.788987104445594
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36181,-0.15546806742724,0.0338934649816695,-0.221899258791312,-0.0890368760631681,4.57592354739883e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36181,-0.0848428848543046,0.0335154169565336,-0.15053310208911,-0.0191526676194986,0.011380698109771
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36181,-0.0738247724125459,0.0335104886823571,-0.139505330229966,-0.00814421459512606,0.0276248614297574
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36181,0.000446336600211047,0.0331900026479731,-0.0646060685898162,0.0654987417902383,0.989270817706253
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36181,0.0293495577275401,0.0334856317296377,-0.0362822804625499,0.09498139591763,0.380798160037276
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36181,-0.0404373136662373,0.0333935751406512,-0.105888720941914,0.025014093609439,0.22596287992272
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36181,-0.0547979893813477,0.034181176681061,-0.121793095676227,0.0121971169135319,0.108943985068051
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36181,0.0500936903159199,0.0332771380604711,-0.0151295002826034,0.115316880914443,0.132279760043921
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36181,-0.00473912914808343,0.0336035430639704,-0.0706020735534653,0.0611238152572985,0.887849808769059
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36181,0.0331683220724363,0.0332902696703073,-0.0320806064813661,0.0984172506262386,0.319121057693347
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36181,-0.0594635677101989,0.0334353325158483,-0.124996819441262,0.00606968402086364,0.0753710485754778
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36181,0.00341099160980983,0.0337647419908699,-0.0627679026922952,0.0695898859119149,0.919535666959132
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36181,0.0461886515379913,0.0331979379082535,-0.0188793067621856,0.111256609838168,0.164175536279481
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36181,-0.0262176087156483,0.0338844192558732,-0.0926310704571598,0.0401958530258631,0.439112898581085
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20631.Liking for cake,36181,0.0977422247922413,0.0335115785447334,0.0320595308445639,0.163424918739919,0.0035491719442591
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36181,0.046002656552046,0.0332587576593302,-0.0191845084602411,0.111189821564333,0.16665570145407
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20633.Liking for capers,36181,-0.106511747824562,0.032825104988995,-0.170848953602992,-0.0421745420461315,0.00118076360063312
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36181,0.00674505390575139,0.0340294010139357,-0.0599525720815626,0.0734426798930654,0.842884553022104
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36181,0.0903480835595337,0.0330133275393987,0.0256419615823122,0.155054205536755,0.00622130422954087
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36181,0.101229962187763,0.03338219959152,0.035800850988384,0.166659073387142,0.00243465769404205
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36181,-0.0200175148862554,0.035431162280535,-0.0894625929561039,0.0494275631835932,0.572112885645878
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36181,-0.00361991380362439,0.0351323249909572,-0.0724792707859006,0.0652394431786518,0.91793691795217
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36181,-0.131111104993171,0.0332065227067817,-0.196195889498463,-0.0660263204878785,7.94642913255954e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36181,0.0284809719888723,0.0336467329760059,-0.0374666246440993,0.094428568621844,0.397319266584979
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36181,0.0256264111104895,0.0567752119301636,-0.0856530042726312,0.13690582649361,0.651739673583729
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20642.Liking for cod,36181,-0.0341342954364523,0.0346371880510536,-0.102023184016517,0.0337545931436127,0.324421960809875
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36181,0.0170682023996745,0.0364428594882139,-0.0543598021972247,0.0884962069965737,0.639545235510095
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36181,-0.0182017606059008,0.033962412365384,-0.0847680888420534,0.0483645676302518,0.592018213122556
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36181,-0.0332563117627908,0.0329758033082259,-0.0978888862469137,0.0313762627213321,0.313246340668898
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36181,0.0539035338561821,0.0333209028955518,-0.0114054358190994,0.119212503531464,0.105770462852104
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20647.Liking for cream,36181,0.0688442979627795,0.0332609256658118,0.00365288365778832,0.134035712267771,0.0385054399519785
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36181,0.0525747576922325,0.0334223790730541,-0.0129331052909535,0.118082620675419,0.115754764388639
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36181,0.0030833262587304,0.0335201486211609,-0.0626161650387449,0.0687828175562057,0.926713181143016
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20650.Liking for curry,36181,-0.0596189321596481,0.0333040389907951,-0.124894848581606,0.00565698426231026,0.0734745563453084
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36181,0.0902305013269074,0.033778755851787,0.0240241398574049,0.15643686279641,0.00757514057367964
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36181,0.0424560907438311,0.0335710896928479,-0.0233432450541507,0.108255426541813,0.206034653329107
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36181,0.0125344895958162,0.0347045383963576,-0.0554864056610446,0.0805553848526771,0.717977885046568
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36181,0.0280192068318232,0.0333265957006445,-0.03730092074144,0.0933393344050864,0.400518971351101
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36181,0.0417091962759676,0.0344498511752582,-0.0258125120275384,0.109230904579474,0.22604293333494
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36181,-0.00992677841269527,0.0331378591601016,-0.0748769823664945,0.0550234255411039,0.764521690546359
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36181,-0.0438590723244607,0.0332367904952379,-0.109003181695127,0.0212850370462056,0.187013869164941
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36181,-0.0612908722279418,0.0335293343834147,-0.127008367619435,0.00442662316355096,0.0675955880690931
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36181,0.0269817366636825,0.0333017248869955,-0.0382896441148286,0.0922531174421937,0.417841147600629
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36181,-0.000136753772845729,0.0358406159438912,-0.0703843610228724,0.070110853477181,0.996955701033955
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36181,-0.00555219484241756,0.0330887766890381,-0.0704061971529323,0.0593018074680972,0.866747907594755
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36181,0.0672772298381263,0.0334855160551591,0.00164561837001458,0.132908841306238,0.0445602850845324
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36181,-0.053951516273944,0.0382345673698226,-0.128891268318796,0.0209882357709084,0.158269594556331
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36181,-0.0645501545930721,0.0334662221747643,-0.13014395005561,0.00104364086946597,0.0537943318408227
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36181,-0.102025468195936,0.0330361649735125,-0.16677635154402,-0.0372745848478514,0.00202098322847096
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36181,-0.132343380981562,0.0333392663010705,-0.19768834293166,-0.0669984190314635,7.27175463504692e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36181,-0.0432058108673931,0.0330557345351661,-0.107995050556319,0.0215834288215325,0.191235583925108
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36181,0.0949056740510585,0.0334788681067359,0.029287092561856,0.160524255540261,0.00459871404960443
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36181,-0.0706640441287494,0.0329858812667293,-0.135316371411539,-0.00601171684595996,0.0322077777505649
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36181,-0.176648933304433,0.033146186957932,-0.24161545974198,-0.111682406866887,1.01628620549114e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36181,0.0541433172879993,0.0331128612437987,-0.0107578907498461,0.119044525325845,0.10207016571301
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36181,-0.117266720318735,0.0336177306541401,-0.183157472400849,-0.0513759682366204,0.000489209557296088
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36181,-0.0546650825551464,0.0344302746631019,-0.122148420894826,0.0128182557845334,0.112398609968981
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20674.Liking for ham,36181,-0.0264135944010642,0.0336253469130272,-0.0923192743505975,0.039492085548469,0.432171726005626
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36181,0.0448434205041135,0.034102963498718,-0.0219983879533739,0.111685228961601,0.188572592058023
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20676.Liking for herring,36181,0.0274128019795599,0.0330800758998951,-0.0374241467842345,0.0922497507433542,0.407313768728252
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20677.Liking for honey,36181,0.0140821779661572,0.0335092810803054,-0.0515960129512414,0.0797603688835559,0.674317895057833
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36181,-0.0956658273368056,0.0331025762834526,-0.160546876852373,-0.0307847778212385,0.00386452317705498
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36181,0.0254735688647829,0.033592925704111,-0.0403685655152748,0.0913157032448405,0.448296067073578
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20680.Liking for jam,36181,0.0322843597799616,0.033582082823376,-0.0335365225538554,0.0981052421137786,0.336406166480454
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36181,0.0044892356559112,0.0336093459796737,-0.0613850824642492,0.0703635537760716,0.893745628971001
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20682.Liking for lager,36181,-0.0645875155784693,0.033600070733125,-0.130443654215394,0.0012686230584557,0.054615800841328
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36181,0.0412576607282012,0.0338852864382913,-0.0251575006908497,0.107672822147252,0.223429124685019
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36181,-0.0631696920901524,0.0332616549116647,-0.128362535717015,0.00202315153671037,0.0575827172477332
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36181,-0.00872138885526596,0.0336498827997022,-0.0746751591426822,0.0572323814321503,0.795503726492391
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20686.Liking for liver,36181,0.0184410752218966,0.0333214792680027,-0.0468690241433887,0.083751174587182,0.5799873697988
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36181,0.0297080030362619,0.0334156566047514,-0.0357866839090508,0.0952026899815745,0.374009853758492
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36181,0.111833136242423,0.0331022960269662,0.0469526360295694,0.176713636455277,0.000733052928481757
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36181,0.0436145198992129,0.033347832835538,-0.0217472324584415,0.108976272256867,0.190961611681469
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20690.Liking for melon,36181,0.00642494089786416,0.0346206949789816,-0.0614316212609398,0.0742815030566681,0.852778800441325
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36181,0.00106974669360127,0.0332384165066867,-0.0640775496595048,0.0662170430467073,0.974326200273041
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36181,0.00517470022882973,0.0341103539584544,-0.0616815935297409,0.0720309939874004,0.879424253731915
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36181,-0.00040058584902415,0.0332276704728628,-0.0655268199758353,0.064725648277787,0.990381448179545
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36181,0.0216858760264919,0.0341505943824276,-0.0452492889630661,0.08862104101605,0.525444487667265
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36181,0.0322328135028551,0.0337573514188381,-0.0339315952780676,0.0983972222837778,0.339692529527696
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20697.Liking for pears,36181,-0.00190078585698688,0.0342830596858952,-0.0690955828413415,0.0652940111273678,0.95578642547234
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36181,0.00951522852673337,0.0333152099429799,-0.0557825829615072,0.074813040014974,0.775183678834332
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36181,0.0907533678512664,0.0333336643505536,0.0254193857241814,0.156087349978351,0.00649364821117996
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20700.Liking for plums,36181,0.02252969604817,0.0340969615259055,-0.0443003485426048,0.0893597406389449,0.508792043940721
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36181,0.0221972453142097,0.0329942015453117,-0.0424713897146012,0.0868658803430206,0.50112098834829
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36181,-0.00491029402766743,0.0332995988049154,-0.0701775076853017,0.0603569196299668,0.882774746265018
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36181,0.0928431093213123,0.0339842192505732,0.0262340395901889,0.159452179052436,0.00631195296352337
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36181,0.013458212341679,0.0332823454023052,-0.0517751846468393,0.0786916093301973,0.685956798710303
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36181,-0.0205388430712136,0.0337312491778825,-0.0866520914598633,0.0455744053174362,0.542612793913588
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36181,0.00845012382250309,0.0339741347924637,-0.0581391803707258,0.075039428015732,0.803582943138457
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36181,0.0412346823864993,0.0333906386443885,-0.0242109693565022,0.106680334129501,0.216902807401844
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36181,0.00672131179170461,0.0334765799461879,-0.0588927849028237,0.072335408486233,0.840879161566496
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36181,-0.109386859627545,0.0332754725762661,-0.174606785877027,-0.0441669333780639,0.00101648930507898
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36181,0.0165479246872748,0.0345684285657678,-0.0512061953016301,0.0843020446761798,0.632166695274915
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36181,0.0125207198515277,0.0350311783771413,-0.0561403897676692,0.0811818294707246,0.720790863352033
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36181,-0.00718540912115848,0.0332918002187295,-0.0724373375498682,0.0580665193075513,0.829125637319792
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36181,-0.0158977179804049,0.0340109011627706,-0.0825590842594354,0.0507636482986255,0.640206807574764
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20714.Liking for salami,36181,0.0127416219156054,0.0332507452404114,-0.0524298387556009,0.0779130825868117,0.701584570433829
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36181,0.0388912824546438,0.0353056056065366,-0.030307704534168,0.108090269443456,0.270690512974299
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36181,-0.0575009675348966,0.0330118786671065,-0.122204249722425,0.00720231465263208,0.0815828577805393
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36181,-0.0256754846258027,0.0334194123012529,-0.0911775327362582,0.0398265634846529,0.442346523149501
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36181,0.0668612035277582,0.0332561455486559,0.00167915825239277,0.132043248803124,0.0444175802956398
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36181,0.0588365187406408,0.0333363467624728,-0.00650272091380584,0.124175758395087,0.0776182571125518
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36181,0.0562251504765829,0.0335939175749378,-0.0096189279702952,0.122069228923461,0.0942401842381344
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36181,-0.0912490379431124,0.0332161076074846,-0.156352608853782,-0.0261454670324426,0.00602731896333863
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36181,-0.0663667797483772,0.0332020224149465,-0.131442743681672,-0.00129081581508203,0.0456603156491261
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36181,-0.0163230603771788,0.0336634343814977,-0.0823033917649143,0.0496572710105568,0.627769645919916
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36181,-0.0316266440660735,0.0334512655695643,-0.0971911245824196,0.0339378364502725,0.344459709217641
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36181,-0.0510653045907021,0.0332681120581801,-0.116270804224735,0.0141401950433309,0.124838375280092
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36181,-0.0218738916017316,0.0334237864574811,-0.0873845130583946,0.0436367298549313,0.512849384814672
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36181,-0.0945020118576174,0.0332556334010412,-0.159683053323658,-0.0293209703915766,0.00450060361793321
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36181,0.00151386212821861,0.0335864238369495,-0.0643155285922024,0.0673432528486396,0.964049907942447
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36181,-0.163967793916183,0.033674485221613,-0.229969784950545,-0.097965802881822,1.14516398012628e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36181,0.0023263602104055,0.0365502881739352,-0.0693122046105074,0.0739649250313184,0.949252171083574
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36181,0.00238486012539343,0.0339868533772004,-0.0642293724939194,0.0689990927447063,0.944060301279191
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36181,0.0622806057391106,0.0335096030958844,-0.00339821632882286,0.127959427807044,0.0631273823910204
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36181,-0.0793663161986417,0.0338455119365177,-0.145703519594216,-0.0130291128030671,0.0190570764869966
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36181,-0.0280532863635222,0.0410786648175925,-0.108567469406004,0.0524608966789591,0.494682457488777
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36181,0.0141944718072375,0.0348585402208169,-0.0541282670255637,0.0825172106400387,0.683872028047212
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36181,-0.0172304962285199,0.0329325763508366,-0.0817783458761596,0.0473173534191199,0.600848054453801
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36181,0.0236600684446721,0.0335375750527859,-0.0420735786587883,0.0893937155481324,0.48053549405736
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36181,-0.0252370555348816,0.0332589489131726,-0.0904245954046999,0.0399504843349367,0.447994864830416
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36181,-0.00417817632657692,0.0366730738330213,-0.0760574010392986,0.0677010483861448,0.909296279946556
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36181,-0.067437857413281,0.0332571365178907,-0.132621844988347,-0.00225386983821518,0.0426215470508314
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36181,-0.041131738509898,0.0335066274892122,-0.106804728388754,0.024541251368958,0.219649750924733
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36181,-0.119254334013683,0.0344746521290681,-0.186824652186657,-0.05168401584071,0.000545043409192353
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36181,0.0132747250922757,0.0330875801221513,-0.0515769319471409,0.0781263821316923,0.688285433658938
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36181,0.0339376248367944,0.0332714569665747,-0.0312744308176919,0.0991496804912808,0.307753292820042
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36181,-0.0857491473447346,0.0333381004119576,-0.151091824152172,-0.0204064705372976,0.0101286762958381
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36181,0.066781671839164,0.0337487617433988,0.000634098822102289,0.132929244856226,0.0478790441982238
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36181,0.0629570151146757,0.0329777718213219,-0.00167941765511524,0.127593447884467,0.0562934893351146
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36181,-0.010464580430943,0.0350038888684187,-0.0790722026130436,0.0581430417511576,0.764983439749937
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36181,-0.11320329302912,0.0332102789054079,-0.17829543968372,-0.0481111463745207,0.000656468040865932
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21001.Body mass index (BMI),52040,-0.259185216437089,0.0201706746076866,-0.298719738668155,-0.219650694206024,1.16751517190646e-37
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21002.Weight,52059,-0.0697188446999095,0.0108845723007471,-0.0910526064093739,-0.0483850829904451,1.53003715043312e-10
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,37009,-0.0137413857138378,0.0074013388920862,-0.0282480099423268,0.000765238514651097,0.0634045359209525
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35991,-0.0439195920598194,0.0358429699683018,-0.114171813197691,0.0263326290780521,0.220492077956768
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36008,-0.0201296937249933,0.0365931310403568,-0.0918522305640926,0.051592843114106,0.582272342388914
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36010,-0.0267041249150682,0.0364615033396466,-0.0981686714607755,0.0447604216306392,0.463954340924964
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,35965,-0.00152622658656507,0.0336962503225876,-0.0675708772188367,0.0645184240457066,0.963874576374896
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35945,-0.00463962423198108,0.0361343667903732,-0.0754629831411126,0.0661837346771505,0.897836884231234
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,35965,-0.00172468360056344,0.0359468409440264,-0.0721804918508551,0.0687311246497282,0.961734613214348
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,35897,-0.0523807997485658,0.0360960099697798,-0.123128979289334,0.0183673797922025,0.146784321903518
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,35928,0.00477457015161073,0.0403196116619238,-0.07425186870576,0.0838010090089814,0.905739953652086
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36014,0.000834670009384847,0.0362915842155521,-0.0702968350530972,0.0719661750718669,0.981651746550662
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36009,-0.0623118599678922,0.0367243104548982,-0.134291508459493,0.00966778852370823,0.0897901934541836
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32787,0.00524429968350888,0.0616962765873625,-0.115680402427722,0.126169001794739,0.932264630842647
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36012,0.0342375383596311,0.0415815615184392,-0.0472623222165096,0.115737398935772,0.410319201440109
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36011,-0.0308433028231283,0.0552305242241972,-0.139095130302555,0.0774085246562982,0.57655774933343
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36009,-0.0242366360853999,0.0420128284706458,-0.106581779887866,0.0581085077170659,0.564035147467312
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36009,-0.184147846262433,0.106115912270192,-0.39213503431201,0.0238393417871444,0.0827247118952155
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36015,0.0211791635234502,0.0429381087302132,-0.0629795295877676,0.105337856634668,0.621852798647662
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36011,-0.113701089284186,0.0399888364697745,-0.192079208764944,-0.0353229698034274,0.0044778934623667
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35854,0.0283634444410547,0.0380421960983019,-0.046199259911617,0.102926148793726,0.455948379687537
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36005,-0.0670173491519502,0.0365077665898124,-0.138572571667983,0.00453787336408208,0.066445445228856
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36011,0.00993397026792627,0.0575324595682668,-0.102829650485877,0.122697591021729,0.862918132405338
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36016,-0.0319564845976192,0.0369944116458006,-0.104465531423388,0.04055256222815,0.387717569947383
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36015,0.0218150703120397,0.0366386271723672,-0.0499966389458,0.0936267795698795,0.551588007751606
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52010,0.0138678542689684,0.0190710605515784,-0.0235114244121253,0.0512471329500621,0.467130851467235
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48245,0.0271188032135517,0.00497593850420874,0.0173659637453026,0.0368716426818008,5.09984717533065e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47070,-0.123318111423895,0.0218672518107606,-0.166177924972985,-0.080458297874804,1.73226957677731e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22032.IPAQ activity group,47054,-0.0609148915568728,0.021732373690572,-0.103510343990394,-0.0183194391233517,0.00506911197819939
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22033.Summed days activity,47557,-0.0190921154200917,0.0049066233215021,-0.0287090971302359,-0.00947513370994763,0.000100146844283231
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22034.Summed minutes activity,47054,-0.0147675426624205,0.00485187124292133,-0.0242772102985463,-0.00525787502629466,0.002340435228825
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46070,-0.0111833400953899,0.00519351876901693,-0.0213626368826631,-0.00100404330811673,0.0313071725104925
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,47054,-0.0121526444340929,0.00473868387988365,-0.0214404648386649,-0.00286482402952096,0.0103387368202211
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,47054,-0.0656807074573527,0.0217171067015694,-0.108246236592429,-0.0231151783222767,0.00249500108309992
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46070,-0.0151506836694265,0.00503616574375796,-0.0250215685271921,-0.00527979881166095,0.00263034650713755
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,50194,-0.00998246615405441,0.00411114833536402,-0.0180403168913679,-0.00192461541674094,0.0151845976807416
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X22501.Year ended full time education,34104,0.0229165699569743,0.0205808464813787,-0.0174218891465279,0.0632550290604765,0.265552480601356
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34073,0.112869390379453,0.0881189422075713,-0.0598437363473865,0.285582517106293,0.200298320516534
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50841,-0.176847100769554,0.0707692422119933,-0.315554815505061,-0.0381393860340469,0.0124643818204787
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23098.Weight,51576,-0.0667078319413677,0.0110143766926152,-0.0882960102588934,-0.045119653623842,1.41392701201615e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23099.Body fat percentage,51568,-0.117251615601603,0.0104388936328109,-0.137711847121912,-0.0967913840812933,3.39254189222906e-29
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23100.Whole body fat mass,51552,-0.122482271437746,0.0102949444015695,-0.142660362464822,-0.10230418041067,1.53229711524466e-32
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51575,0.0121724723910433,0.00897569699215809,-0.00541989371358659,0.0297648384956731,0.175062260514003
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23102.Whole body water mass,51576,0.0138649666859462,0.00900617756975393,-0.00378714135077149,0.0315170747226639,0.123697597628238
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23104.Body mass index (BMI),51576,-0.251865788634854,0.0202420296925333,-0.29154016683222,-0.212191410437489,2.0068514028975e-35
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23105.Basal metabolic rate,51576,6.61989890114566e-05,0.00958955346300578,-0.0187293257984799,0.0188617237765028,0.9944921166578
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23106.Impedance of whole body,51573,-0.0500756430951178,0.00731994662931121,-0.0644227384885678,-0.0357285477016678,8.06794043856943e-12
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23107.Impedance of leg (right),51576,-0.0778038612682391,0.00589034737385508,-0.0893489421209951,-0.0662587804154832,1.10039820941987e-39
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23108.Impedance of leg (left),51576,-0.0819517091292263,0.00585113688156269,-0.0934199374170892,-0.0704834808413634,2.20222206589787e-44
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23109.Impedance of arm (right),51573,0.015724166940089,0.00723522849332819,0.00154311909316571,0.0299052147870122,0.0297698101647689
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23110.Impedance of arm (left),51576,0.00978704126804566,0.00726846956162694,-0.00445915907274314,0.0240332416088345,0.178152871468475
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51576,-0.18754739825856,0.0122562922691962,-0.211569731106184,-0.163525065410935,1.36639024101253e-52
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23112.Leg fat mass (right),51576,-0.194002087184788,0.0134452809954861,-0.220354837935941,-0.167649336433635,5.52541376908094e-47
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51575,0.0491600482355376,0.00912412767419611,0.0312767579941133,0.067043338476962,7.19982830923652e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51575,0.0494336456802927,0.00918031409579478,0.031440230052535,0.0674270613080505,7.32783403436783e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51573,-0.207183913761615,0.0128873172173828,-0.232443055507686,-0.181924772015545,7.8545436399734e-58
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23116.Leg fat mass (left),51573,-0.213491193959959,0.0140790380041136,-0.241086108448022,-0.185896279471897,1.11039543810747e-51
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51572,0.0462805292825843,0.00960213998670679,0.027460334908639,0.0651007236565296,1.4463422671536e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51572,0.0481087334377138,0.00966240440806567,0.0291704207979051,0.0670470460775225,6.44017389687309e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51572,-0.0531260298113738,0.0118231448604139,-0.076299393737785,-0.0299526658849625,7.0448407883549e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23120.Arm fat mass (right),51570,-0.0923970628561247,0.0118019743377543,-0.115528932558123,-0.0692651931541263,5.13709128060361e-15
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51571,-0.0317892544617221,0.00917447306687127,-0.0497712216727898,-0.0138072872506544,0.000531288178599761
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51571,-0.0343953646191428,0.00919074644216703,-0.0524092276457902,-0.0163815015924954,0.000182733381877499
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51570,-0.0611670142865239,0.0120966811383153,-0.0848765093176219,-0.037457519255426,4.30363659043986e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23124.Arm fat mass (left),51570,-0.10251856651316,0.0118099037692668,-0.125665977900923,-0.079371155125397,4.1964019993479e-18
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51570,-0.0292111559577162,0.00936434649330296,-0.04756527508459,-0.0108570368308424,0.00181448999851463
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51568,-0.02934110268427,0.00937208381170589,-0.0477103869552135,-0.0109718184133264,0.00174619721648726
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23127.Trunk fat percentage,51567,-0.0645415819999995,0.00747847341933165,-0.0791993899018895,-0.0498837740981094,6.51946264886803e-18
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23128.Trunk fat mass,51567,-0.0791077742710956,0.00835982841951071,-0.0954930379733366,-0.0627225105688546,3.2833524050961e-21
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51566,-0.00332106611398088,0.00809966607131677,-0.0191964116137617,0.0125542793858,0.681791486396218
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23130.Trunk predicted mass,51563,-0.00284532520432331,0.00812310222932999,-0.0187666055738101,0.0130759551651635,0.726135108817539
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42495,-0.166015542817536,0.0056318129095221,-0.1770538961202,-0.154977189514873,4.57733466637371e-185
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42495,-0.187444381244215,0.00540696895050514,-0.198042040387205,-0.176846722101225,3.4248981994305e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42495,-0.174614554856996,0.00543366772274461,-0.185264543593575,-0.163964566120417,2.76724252850509e-218
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42495,-0.183718842089495,0.00551213259477122,-0.194522621975246,-0.172915062203743,5.20642606881321e-234
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42495,-0.185090083573739,0.00540277424265914,-0.195679521089351,-0.174500646058127,1.4350864976418e-246
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42495,-0.193639147397054,0.00541127916974255,-0.20424525456975,-0.183033040224359,7.75890707572971e-268
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42495,0.024788770359153,0.00647586493299014,0.0120960750904923,0.0374814656278136,0.000129849067668047
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42495,-0.148679563489208,0.00605747353396089,-0.160552211615772,-0.136806915362645,3.77647334691318e-130
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42495,-0.151295103470707,0.00602898939245657,-0.163111922679921,-0.139478284261492,8.01764825820634e-136
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42495,-0.147415891708859,0.00600786523281821,-0.159191307565183,-0.135640475852536,4.52232777051885e-130
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42495,-0.075456124213243,0.00602981655570182,-0.0872745646624185,-0.0636376837640674,9.96707892823695e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42495,-0.145447259292155,0.00589528273746864,-0.157002013457594,-0.133892505126717,1.89182370690132e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42495,-0.180629274999946,0.00570945165968318,-0.191819800252925,-0.169438749746967,7.32824791071445e-212
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42495,-0.194837108611164,0.00537289618221752,-0.20536798512831,-0.184306232094017,1.15482899685625e-274
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42495,0.0192566792994596,0.0064410087375861,0.00663230217379086,0.0318810564251284,0.00279762968703055
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42495,-0.163293360689368,0.0056659828050967,-0.174398686987357,-0.152188034391378,3.17676839611857e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42495,-0.177201234082432,0.00545812139369909,-0.187899152014082,-0.166503316150782,1.40029626410122e-222
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42495,-0.199766456077586,0.00540468671773798,-0.210359642044353,-0.18917327011082,9.15713612875934e-285
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42495,0.0273051263604964,0.00644175475457958,0.0146792870415204,0.0399309656794723,2.26262611348834e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42495,-0.169964969001263,0.00555779209715836,-0.180858241511693,-0.159071696490833,1.484803478021e-198
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42495,-0.188102612971213,0.00562143663205606,-0.199120628770043,-0.177084597172383,8.94978630281782e-236
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42495,-0.171790778070066,0.00546861230273017,-0.182509258183417,-0.161072297956715,5.10250892156393e-209
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42495,0.0163473005527235,0.00654466872436568,0.00351974985296677,0.0291748512524802,0.0125085040192387
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42495,-0.177692249120311,0.00560314812037352,-0.188674419436244,-0.166710078804379,7.78613774866201e-213
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42495,-0.175876332002286,0.0058028161347153,-0.187249851626328,-0.164502812378244,3.50553814970976e-195
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42495,-0.19662352764192,0.00540031654034173,-0.20720814806099,-0.186038907222851,9.02308250843386e-277
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42495,0.0162120775472694,0.00647495844691482,0.00352115899131632,0.0289029961032224,0.0122982167057742
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42495,-0.113603376917439,0.00604019546378683,-0.125442160026461,-0.101764593808416,6.64834406964842e-78
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42495,-0.179828573545546,0.00563048409556634,-0.190864322372856,-0.168792824718236,9.83568088750257e-216
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42495,-0.186380572860451,0.00538196923829061,-0.1969292325675,-0.175831913153401,1.09806953830466e-251
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42495,-0.0842281022566096,0.00608696656087343,-0.0961585567159215,-0.0722976477972977,3.01918927828444e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42495,-0.142050679047554,0.00615795032518656,-0.154120261684919,-0.129981096410188,1.77217179304648e-115
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42495,0.0272367026242198,0.00595590573666707,0.0155631273803524,0.0389102778680873,4.84994407700708e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42495,0.169747360984699,0.00653705177013371,0.156934739515237,0.182559982454161,4.67041719972284e-145
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42483,-0.123999658719361,0.00605236372847277,-0.135862291627168,-0.112137025811555,7.21859033455864e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42483,-0.111046093957123,0.00635187607949064,-0.123495771072924,-0.0985964168413209,1.11388274633733e-67
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23436.Total Cholines,42483,-0.126382231022396,0.00605427996315811,-0.138248619750186,-0.114515842294606,3.03822103140083e-95
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42483,-0.115510589498295,0.00612084015349535,-0.127507436199146,-0.103513742797444,2.05978803802114e-78
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42483,-0.128482691615531,0.00593002223196905,-0.140105535190191,-0.116859848040872,2.48391757829587e-102
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42495,-0.183941451530929,0.00538549925978493,-0.194497030080108,-0.173385872981751,3.71415568242779e-245
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42495,-0.0221177822744517,0.00632298331120872,-0.0345108295644208,-0.00972473498448265,0.000470295968871198
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42495,-0.155590021527386,0.00558926474395924,-0.166544980425546,-0.144635062629225,8.27279002362391e-166
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42483,-0.164049389887223,0.00581470040178101,-0.175446202674714,-0.152652577099732,3.98311569181719e-170
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42483,0.043216482162439,0.00605270604554909,0.0313531783131628,0.0550797860117152,9.81625223876332e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42483,-0.0697628511183843,0.00599976072976779,-0.0815223821487292,-0.0580033200880394,4.21945113460929e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42483,-0.14928956904,0.00575022883583606,-0.160560017558238,-0.138019120521761,5.27025986801473e-145
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42483,-0.14825216027513,0.00583485989332978,-0.159688485666056,-0.136815834884204,4.18901788591532e-139
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42483,-0.148154821952432,0.00599627554068741,-0.159907522012179,-0.136402121892684,8.12336029944225e-132
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42483,-0.169432228652598,0.00580431911605181,-0.18080869412006,-0.158055763185137,1.285658119141e-181
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42483,-0.127875669299616,0.00566658618201457,-0.138982178216364,-0.116769160382867,1.09472959960945e-110
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42483,-0.0520630824398822,0.00599722336034528,-0.0638176402261589,-0.0403085246536054,4.36834352385775e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42483,0.0119673600186667,0.00595920117440425,0.000287325716834335,0.023647394320499,0.0446405966417174
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42483,0.0979920279567447,0.00636070964093262,0.0855250370605168,0.110459018852973,4.29975819208152e-53
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42483,0.104089680910854,0.00626682851213038,0.0918066970270787,0.11637266479463,2.46215425878499e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42483,-0.065085247738505,0.00638028321129979,-0.0775906028326526,-0.0525798926443574,2.4127033463161e-24
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42483,-0.0973574211310929,0.00576014571991453,-0.108647306742125,-0.0860675355200604,2.00024678530889e-63
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42483,0.0358149388357988,0.00615013520528579,0.0237606738334386,0.0478692038381589,5.89816733460995e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42483,0.0440858515383908,0.00592479714531597,0.0324732491335715,0.0556984539432101,1.06136176189431e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42483,0.0873478104235154,0.00637636680593571,0.0748501314838814,0.0998454893631494,2.00689473259923e-42
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42483,0.0122049428651717,0.00589954673852841,0.000641831257656055,0.0237680544726874,0.0385847780797007
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23460.Alanine,42489,0.0295571009141896,0.00581537102182101,0.0181589737114205,0.0409552281169588,3.77394498113691e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23461.Glutamine,42455,0.0529208505582494,0.00581458769738342,0.0415242586713779,0.0643174424451209,1.01755960386455e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23462.Glycine,42479,0.0860336541118686,0.00615448559210125,0.0739708623513501,0.098096445872387,4.29651184581792e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23463.Histidine,42475,0.0221075244325416,0.0057268927532902,0.0108828146360928,0.0333322342289904,0.000113784312568533
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42485,0.0407749192139033,0.00605766932440643,0.0289018873380667,0.0526479510897399,1.75266003882287e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23465.Isoleucine,42491,0.0842043425719724,0.00586216069310207,0.0727145076134924,0.0956941775304525,1.93590684802632e-46
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23466.Leucine,42491,0.0272563378293676,0.00597811717291475,0.0155392281704547,0.0389734474882805,5.17696788655509e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23467.Valine,42485,0.028924627796702,0.00612353881322689,0.0169224917227773,0.0409267638706267,2.34174128140984e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42487,0.107714299880822,0.00573274497371439,0.0964781197323422,0.118950480029303,9.36652290422116e-78
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23469.Tyrosine,42478,0.0695808791073323,0.00586758501044076,0.0580804124868684,0.0810813457277962,2.82763989281329e-32
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23470.Glucose,42467,0.0150984904619906,0.0057463257593001,0.00383569197376241,0.0263612889502188,0.00861128970160631
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23471.Lactate,42469,-0.0407207745115942,0.005744476719103,-0.051979948881036,-0.0294616001421523,1.42237180164165e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23472.Pyruvate,42458,-0.000207506280734441,0.00581125556404886,-0.0115975671862702,0.0111825546248013,0.971516007817207
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23473.Citrate,42492,0.0225676114964971,0.00581561790240011,0.0111690004077928,0.0339662225852013,0.000104737058566486
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,42270,-0.0776118347251975,0.00607981999212034,-0.0895282819097534,-0.0656953875406417,4.25460008156064e-37
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23475.Acetate,42483,0.0371134443443648,0.00570885947460754,0.0259240797741341,0.0483028089145956,8.26240796970118e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42493,-0.0163277478793883,0.00588420024501474,-0.0278607803596172,-0.00479471539915942,0.00553049841590406
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23477.Acetone,42493,0.00746980866846098,0.00582358109311492,-0.00394441027404427,0.0188840276109662,0.199625501084559
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23478.Creatinine,42182,0.0552605581411036,0.00647173785480027,0.042575951945695,0.0679451643365121,1.50660019038268e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23479.Albumin,42492,-0.0517332415800883,0.00582199151422494,-0.0631443449479692,-0.0403221382122074,7.15103061045913e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42495,-0.0586049674110075,0.00616076716911231,-0.0706800710624676,-0.0465298637595474,2.17458535233944e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42495,-0.116865364669468,0.00612761033044522,-0.128875480917141,-0.104855248421796,5.03588671532309e-80
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42495,-0.113052408879035,0.00606096299809341,-0.124931896355298,-0.101172921402772,1.14130261218926e-76
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42495,-0.11618846347501,0.00614161749573148,-0.128226033766643,-0.104150893183376,8.71033602320163e-79
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42495,-0.140655321225079,0.00604538728857429,-0.152504280310685,-0.128806362139473,2.1050734115234e-117
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42495,-0.150976858738531,0.00595643001378348,-0.162651461565546,-0.139302255911515,1.83189445420779e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42495,-0.123416134767454,0.00613323859368794,-0.135437282411083,-0.111394987123826,9.75551734408071e-89
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42495,-0.0966381975325693,0.00601985765741732,-0.108437118541107,-0.0848392765240314,1.87865105711861e-57
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42495,-0.165766095142622,0.00602522137564886,-0.177575529038894,-0.15395666124635,4.15844237611524e-162
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42495,-0.163079022122988,0.00599757051610827,-0.17483426033456,-0.151323783911416,1.72118070708626e-158
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42495,-0.163869184976472,0.00597567045032602,-0.175581499059111,-0.152156870893834,4.25015758684707e-161
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42495,-0.184952058499253,0.00578825683876693,-0.196297041903236,-0.17360707509527,6.37623097751047e-216
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42495,-0.195012550191104,0.0056655249061168,-0.206116979007093,-0.183908121375115,8.47024184178099e-249
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42495,-0.167180426676014,0.00592137250374059,-0.178786316783345,-0.155574536568682,2.28181603120585e-170
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42495,-0.147936720037222,0.00606121139681566,-0.159816694374981,-0.136056745699463,9.5495844720453e-129
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42495,-0.172851881706577,0.00593862550712969,-0.184491587700551,-0.161212175712603,1.28496589238732e-180
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42495,-0.172006424492469,0.00590391338258507,-0.183578094722335,-0.160434754262602,5.97674033318679e-181
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42495,-0.171354490626942,0.00593424804521927,-0.182985616795572,-0.159723364458312,7.01529476489562e-178
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42495,-0.18252708909353,0.00578654622283413,-0.193868719690285,-0.171185458496775,1.14768101372104e-210
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42495,-0.178123555517739,0.00568769976204299,-0.189271447051344,-0.166975663984135,8.60431279347658e-208
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42495,-0.183733023315133,0.00589728087529135,-0.195291693830704,-0.172174352799562,9.58234827719657e-206
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42495,-0.159247862189551,0.00592465023561953,-0.170860176651365,-0.147635547727737,5.16168579057618e-155
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42495,-0.194709361140778,0.00549058669684094,-0.205470911066586,-0.183947811214969,2.75802826079787e-263
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42495,-0.190921347523637,0.00556735826482923,-0.201833369722702,-0.180009325324572,4.81499396606231e-247
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42495,-0.1896520437997,0.00547791719854012,-0.200388761508839,-0.178915326090561,1.4784935529639e-251
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42495,-0.17001628341754,0.00541344657070272,-0.180626638696117,-0.159405928138962,6.38681253002474e-209
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42495,-0.150310756186812,0.00547150948083335,-0.161034914769245,-0.139586597604379,1.19423812838535e-161
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42495,-0.186355587037308,0.00544219049858874,-0.197022280414542,-0.175688893660075,2.3449501263129e-246
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42495,-0.170631726596649,0.00584928673958197,-0.18209632860623,-0.159167124587069,2.16191415600795e-181
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42495,-0.176066852496199,0.00573419966830132,-0.187305883846069,-0.164827821146328,4.33713603172896e-200
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42495,-0.181287155773673,0.00570432433530959,-0.19246763147088,-0.170106680076466,1.05318957104713e-213
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42495,-0.191542975836123,0.00553075802057821,-0.202383261556457,-0.18070269011579,1.03812798543403e-251
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42495,-0.189717464720386,0.00547724791725341,-0.200452870638202,-0.178982058802569,8.84090256826731e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42495,-0.187001705437556,0.00551558008546339,-0.197812242405064,-0.176191168470048,9.56885401885077e-242
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42495,-0.189994075762745,0.00542844380902079,-0.200633825628425,-0.179354325897064,8.3298455253134e-257
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42495,-0.128356503523841,0.00603505325623358,-0.140185207906058,-0.116527799141623,9.71692574377309e-99
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42495,-0.141159801543786,0.00563960792278382,-0.152213433072442,-0.13010617001513,3.76546453704166e-135
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42495,-0.133081737586314,0.00571028435235354,-0.144273894916927,-0.121889580255701,8.76841803708827e-118
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42495,-0.126708488794823,0.00572502363767571,-0.137929535124668,-0.115487442464979,1.28135647212271e-106
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42495,-0.123595732610429,0.00564347215493432,-0.134656938034101,-0.112534527186758,1.77819691919556e-104
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42495,-0.115725722148809,0.00566126959533054,-0.126821810555657,-0.104629633741961,1.80220872183401e-91
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42495,-0.137978121464278,0.00565427311829497,-0.149060496776136,-0.12689574615242,1.0652251499417e-128
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42495,-0.108930456662583,0.00605797479868267,-0.120804087268001,-0.0970568260571652,1.9094675854923e-71
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42495,-0.151064568628204,0.00542687875693504,-0.161701250991796,-0.140427886264611,8.47871183231647e-166
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42495,-0.145692578905315,0.00560296971236118,-0.156674399541543,-0.134710758269087,1.92524832008704e-145
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42495,-0.141307282630611,0.00562613722331992,-0.152334511588318,-0.130280053672904,4.77208324787839e-136
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42495,-0.139399297097312,0.00560930466844711,-0.150393534247469,-0.128405059947156,2.67442297736775e-133
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42495,-0.138682419003862,0.005614892912542,-0.149687609112444,-0.12767722889528,9.9381824546993e-132
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42495,-0.137978519527847,0.00559792282395323,-0.148950448262796,-0.127006590792899,3.30662149804749e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42495,-0.114554666694173,0.00605069551612477,-0.126414029905777,-0.102695303482568,6.69241784794674e-79
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42495,-0.171446125055304,0.00541620427538477,-0.182061885435059,-0.16083036467555,4.38819226836967e-212
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42495,-0.184882318274633,0.00546263979274979,-0.195589092268423,-0.174175544280843,6.10990524627107e-241
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42495,-0.186790409795893,0.00541394808945889,-0.197401748051233,-0.176179071540554,6.56165715924731e-250
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42495,-0.180196983740553,0.0054851344972297,-0.190947847355124,-0.169446120125983,1.1735766250172e-227
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42495,-0.184959737843263,0.00547531180364036,-0.195691348978398,-0.174228126708128,4.51647583464564e-240
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42495,-0.163265633650679,0.00552900606477641,-0.17410248553764,-0.152428781763717,1.12065413497853e-185
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42495,-0.142681259055298,0.00600119486308167,-0.154443600986938,-0.130918917123658,2.10489782698453e-122
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42495,-0.207782690206635,0.00536211763602377,-0.218292440773241,-0.197272939640028,1.66943587497214e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42495,-0.217471869848374,0.00536416219842406,-0.227985627757285,-0.206958111939462,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42495,-0.211351827138195,0.00536804658720877,-0.221873198449124,-0.200830455827266,1.66880539388061e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42495,-0.216931607210096,0.00535212065463949,-0.22742176369319,-0.206441450727003,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42495,-0.223420603129983,0.00536612738603255,-0.233938212806607,-0.212902993453359,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42495,-0.189196299617137,0.00540444214344631,-0.199789006218292,-0.178603593015982,6.48131619924494e-257
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42495,-0.156173930496835,0.00600360967936343,-0.167941005468387,-0.144406855525283,1.48056829101554e-145
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42495,-0.18535573808433,0.00539003452929051,-0.195920205761739,-0.174791270406921,2.35321626511909e-248
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42495,-0.19792257820107,0.00535959554528101,-0.208427385469821,-0.18741777093232,2.77530048709214e-284
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42495,-0.172416234957533,0.00537647368854505,-0.182954123387081,-0.161878346527984,2.04232495808105e-217
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42495,-0.202450864247187,0.00534515544539584,-0.212927368920163,-0.191974359574211,3.27879066595022e-298
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42495,-0.20967311485922,0.0053626952055185,-0.220183997462036,-0.199162232256404,1.66880539711489e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42495,-0.167673959776533,0.00541230940781243,-0.178282086215845,-0.15706583333722,1.55124907997151e-203
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42495,-0.139269487185883,0.00607018002274516,-0.151167040030464,-0.127371934341303,2.80735735677111e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42495,0.0878883838589246,0.00636781411870471,0.0754074681862634,0.100369299531586,4.90807387194266e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42495,0.124516272824366,0.00635835135515856,0.112053904168255,0.136978641480477,3.29210933134996e-84
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42495,0.147383766356864,0.00636680236374132,0.134904833723931,0.159862698989797,2.92493972733585e-116
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42495,0.103267430427596,0.00632048880933141,0.0908792723613067,0.115655588493886,1.9887985056431e-59
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42495,0.100994270873916,0.00638667277062499,0.088476392243491,0.113512149504341,8.11929208045732e-56
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42495,0.106767506664148,0.00604596567764849,0.0949174139359573,0.118617599392339,5.28102849938447e-69
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42495,-0.037114284055061,0.00601934796274739,-0.0489122060620459,-0.0253163620480761,7.21426515156565e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42495,0.104078565103607,0.00663868574470937,0.0910667410439764,0.117090389163237,6.669751635909e-55
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42495,0.117004202212098,0.00663470130689215,0.104000187650589,0.130008216773606,8.01397365741412e-69
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42495,0.120025408212974,0.00662660911365339,0.107037254350213,0.133013562075734,1.87614247656251e-72
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42495,0.113315360667061,0.00657046708487497,0.100437245180706,0.126193476153416,6.22267461204966e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42495,0.113632842381474,0.0065592123605793,0.100776786154739,0.126488898608209,1.65746047264434e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42495,0.111297398025554,0.00658288458900505,0.0983949442311036,0.124199851820003,1.83277113655798e-63
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42495,0.0213202306607231,0.00622291310128651,0.00912332098220149,0.0335171403392446,0.00061419925407552
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42495,-0.00996655811539912,0.00627516056414049,-0.0222658728211145,0.00233275659031623,0.112252350169976
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42495,-0.011037938432364,0.00622595072377077,-0.0232408018509547,0.00116492498622668,0.0762694806820168
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42495,-0.0125753443571234,0.0061960673112023,-0.0247196362870799,-0.000431052427166911,0.0424202658407743
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42495,0.0017182396377392,0.00625599492589724,-0.0105435104170194,0.0139799896924978,0.783585652015047
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42495,0.00388950142812821,0.00622345325264084,-0.00830846694704785,0.0160874698033043,0.53199832107389
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42495,-0.00739222191803199,0.0063655405090687,-0.0198686813158066,0.00508423747974266,0.245545885949709
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42495,-0.0758901130962606,0.00600177999800401,-0.0876536018923484,-0.0641266243001727,1.94164775323647e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42495,-0.191664173267936,0.00553014060165825,-0.202503248847187,-0.180825097688686,4.57232468378165e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42495,-0.16915994607792,0.00563710253503914,-0.180208667046596,-0.158111225109243,1.70775403068689e-191
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42495,-0.145360063795492,0.00572282421751145,-0.156576799261814,-0.134143328329169,5.0465582615885e-139
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42495,-0.177730656747282,0.00555624772973588,-0.188620902297565,-0.166840411197,2.28361366035859e-216
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42495,-0.173408244658432,0.00553127198598405,-0.18424953775096,-0.162566951565903,3.26337833706733e-208
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42495,-0.165351713239301,0.0057421569442156,-0.176606340849964,-0.154097085628639,6.07094161941868e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42495,-0.136819335990971,0.00603173828515148,-0.148641543029868,-0.124997128952074,8.54886819218373e-112
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42004,0.00540281777247322,0.00589751551160332,-0.00615631263026929,0.0169619481752157,0.359622461640887
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42004,-0.0359336769073381,0.00607525306923241,-0.0478411729230336,-0.0240261808916426,3.40833945260635e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42004,-0.0693663581409393,0.00599397790621117,-0.0811145548371132,-0.0576181614447654,8.0669233033513e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42004,0.0264996937300734,0.00610982216971196,0.014524442277438,0.0384749451827089,1.45394354542096e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42004,0.0345764078199594,0.00602485916274991,0.0227676838609696,0.0463851317789492,9.741952497647e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42377,-0.075522436620344,0.0058198373192073,-0.0869293177659903,-0.0641155554746977,2.84415925346348e-38
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42377,0.0122445770114668,0.00613118669841845,0.000227451082566679,0.024261702940367,0.0458351231285924
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42377,0.008636333284736,0.00614000055709471,-0.00339806780716963,0.0206707343766416,0.15957885875312
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42377,0.0162310409598601,0.00604884358898715,0.00437530752544529,0.0280867743942749,0.00729840996537626
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42377,0.0116205576688498,0.00601615766987534,-0.000171111364105889,0.0234122267018055,0.0534354878355095
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42494,-0.1078873607847,0.00593591153938675,-0.119521747401898,-0.096252974167502,6.15990163434552e-73
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42494,-0.0225521063276317,0.00582901844083258,-0.0339769824716636,-0.0111272301835999,0.000109832220394355
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42494,0.00882989958711266,0.00600263465840602,-0.00293526434336315,0.0205950635175885,0.141313693330415
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42494,-0.0907908087316239,0.00570192459621987,-0.101966580940215,-0.0796150365230329,1.46453162240929e-56
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42494,0.0642562962663766,0.00571253899528769,0.0530597198356127,0.0754528726971404,3.19926472384225e-29
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42495,-0.063386863366862,0.00579598030100415,-0.0747469847568302,-0.0520267419768939,1.01367819374207e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42495,-0.011268961267208,0.00604031599500185,-0.0231079806174117,0.000570058082995577,0.0621159220841632
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42495,-0.000348975620657619,0.00610498283599256,-0.012314741979203,0.0116167907378878,0.954416668707241
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42495,-0.040776621285705,0.00588497664163355,-0.0523111755033067,-0.0292420670681032,4.43539075396221e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42495,0.0233398914950449,0.00598334804349088,0.0116125293298028,0.0350672536602871,9.63438961839494e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42495,-0.064991801246387,0.00599252196711632,-0.0767371443019349,-0.053246458190839,2.72529268501118e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42495,-0.0808515938316631,0.00582803566803889,-0.0922745437410193,-0.0694286439223069,1.8565351420738e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42495,-0.0851275978070731,0.00571645989507855,-0.0963318592014271,-0.0739233364127192,9.39159386051568e-50
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42495,-0.0656210747279874,0.00601588824395448,-0.0774122156861382,-0.0538299337698366,1.38184695643628e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42495,0.0773312052181293,0.00588196913095168,0.065802545721464,0.0888598647147945,3.10290096288299e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42495,0.0361346094556085,0.00587417827990029,0.0246212200270039,0.0476479988842131,7.89878295356903e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42495,-0.0241565243057999,0.00609434678943522,-0.0361014440130929,-0.0122116045985068,7.41642994478913e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42495,-0.0128566745942646,0.0061469724084154,-0.0249047405147587,-0.000808608673770387,0.0364980806786089
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42495,-0.0977686614752826,0.00572159556539288,-0.108982988783453,-0.0865543341671126,8.99529035288033e-65
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42495,0.0192498026481559,0.00607222779658886,0.00734823616684176,0.0311513691294701,0.00152711817090989
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42495,0.0725058461070878,0.00551549149202289,0.0616954827827229,0.0833162094314526,3.1563565894029e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42495,-0.0576011668512339,0.00585404190756951,-0.0690750889900701,-0.0461272447123977,9.09476572669177e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42495,-0.0511250508683988,0.00585181704606418,-0.0625946122786846,-0.039655489458113,2.68656198275557e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42495,-0.0340628079534315,0.00564671635016185,-0.0451303719997487,-0.0229952439071143,1.65910270352043e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42495,0.0456688746563884,0.00605212065822357,0.0338067181662702,0.0575310311465067,4.78221235288359e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42495,0.00597088159634177,0.00563360972484734,-0.00507099346435903,0.0170127566570426,0.289223987851806
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42495,-0.0737370679761045,0.00606365646035816,-0.0856218346384065,-0.0618523013138025,7.62885287141168e-34
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42495,-0.100003502420509,0.00562975041110819,-0.111037813226281,-0.0889691916147369,8.66859235072583e-70
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42495,0.0168637624743763,0.00608956979401503,0.00492820567810688,0.0287993192706458,0.00562570731083062
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42495,0.0751130379475037,0.00604973550540533,0.0632555563569093,0.0869705195380982,3.35600769621741e-35
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42495,0.104645212788307,0.00569546743529298,0.0934820966151324,0.115808328961481,1.78481529413478e-74
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42495,-0.127115431266519,0.00551572663353678,-0.137926255468251,-0.116304607064787,2.87939742743669e-115
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42495,-0.162488197499064,0.00564701766099776,-0.173556352114619,-0.151420042883508,1.10082434724251e-176
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42495,0.0671771413699597,0.00619577176883639,0.0550334287030404,0.0793208540368791,2.81741097643947e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42495,0.0976931664097139,0.00592114487818846,0.0860877224484645,0.109298610370963,1.48813033561233e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42495,0.156422217266263,0.00555406833519996,0.145536243329271,0.167308191203255,1.46718730459987e-169
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42495,-0.160808168112802,0.00557382469112033,-0.171732864507398,-0.149883471718206,1.38160684444694e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42495,-0.16167853897278,0.00554453496693155,-0.172545827507966,-0.150811250437594,2.95538000338568e-181
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42495,0.0120837766129876,0.00610165949148077,0.00012452400968534,0.0240430292162899,0.0476782479066976
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42495,0.0314589809448407,0.00609362346666678,0.0195154789501738,0.0434024829395076,2.47047120220965e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42485,0.202943527643153,0.00610959717510834,0.190968717179941,0.214918338106366,1.69237045661168e-232
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42485,-0.14370780914923,0.00587078117816106,-0.155214540258425,-0.132201078040034,1.80262424020394e-129
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42485,-0.110059178857196,0.00575314389008783,-0.121335340881768,-0.0987830168326238,1.70054226987108e-80
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42485,-0.110645693202583,0.00656855855370078,-0.123520067967836,-0.0977713184373292,5.15800203611762e-63
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42485,-0.133160882051072,0.00624155910456942,-0.145394337896028,-0.120927426206116,2.4916999330491e-99
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42495,-0.028829357046811,0.0061696898706122,-0.0409219491932109,-0.0167367649004111,3.00121964844687e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42495,0.0714288663213711,0.00635016805502885,0.0589825369335146,0.0838751957092277,3.19730678286525e-29
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42495,0.0611969214337619,0.00640525413270828,0.0486426233336536,0.0737512195338701,1.46084689802794e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42495,0.0541028324382101,0.00603122141599981,0.0422816384628504,0.0659240264135697,3.34331613825326e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42495,-0.0823751342005194,0.00626952911307401,-0.0946634112621445,-0.0700868571388944,3.45314631837621e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42495,-0.0126535104952426,0.00626561023733364,-0.0249341065604166,-0.000372914430068689,0.0434534597021518
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42495,0.0492862267200853,0.00619999477549059,0.0371342369601237,0.0614382164800469,2.02456473386353e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42495,0.0509398211692721,0.00616441170410018,0.0388575742292358,0.0630220681093085,1.54723837003176e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42495,0.00921907299463001,0.00649768726535445,-0.00351639404546473,0.0219545400347247,0.155973838683964
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42495,-0.0691715312339616,0.00610632156430008,-0.0811399214999897,-0.0572031409679334,1.30525828405131e-29
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42495,0.145707788759534,0.0058689729876694,0.134204601703702,0.157210975815366,4.80519716494974e-133
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42495,-0.052198643866961,0.00598035045966627,-0.0639201307679069,-0.0404771569660151,2.88877810539591e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42495,-0.0578219879822695,0.00603699131864641,-0.0696544909668164,-0.0459894849977225,1.16270006335133e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42495,-0.0114110535209495,0.00598680289708997,-0.0231451871992458,0.000323080157346847,0.0566672485919459
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42495,-0.0689382823710376,0.00616483612827335,-0.0810213611824533,-0.0568552035596218,6.68299142556482e-29
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51868,-0.000890118564258135,0.00495776457246457,-0.0106073371262887,0.00882709999777242,0.857515076827576
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51868,0.00419070113629873,0.00482670734039374,-0.005269645250873,0.0136510475234705,0.385276600273984
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50425,0.00635970786197566,0.0046026797460422,-0.00266154444026706,0.0153809601642184,0.167066009769444
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50425,0.00526245926245068,0.00505594819397511,-0.00464719919774053,0.0151721177226419,0.297959264249132
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50425,-0.0025678918418297,0.00493191704657038,-0.0122344492531076,0.00709866556944825,0.602603435145498
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50425,0.00327780789828067,0.00449871788354129,-0.00553967915346026,0.0120952949500216,0.466248695861148
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51868,0.0223674899797149,0.0421605859752117,-0.0602672585317,0.10500223849113,0.595749146642128
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51868,-0.00316677439709308,0.00433594516066424,-0.011665226911995,0.00533167811780882,0.465181444001733
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51868,0.00266571228192056,0.00428120814900737,-0.00572545569013388,0.011056880253975,0.533518040517497
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51868,0.0014009602997043,0.00436473442223964,-0.00715391916788538,0.00995583976729399,0.748234088452177
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51868,-0.0019291205760743,0.0297010377020367,-0.0601431544720663,0.0562849133199177,0.948213359554752
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51868,-0.00706545186306071,0.0288359318307316,-0.0635838782512946,0.0494529745251731,0.806441233819632
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51868,-0.000317994964254091,0.00493309688585979,-0.00998686486053927,0.00935087493203109,0.948603307645733
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51868,0.000287598954395042,0.00492245407592687,-0.00936041103442162,0.00993560894321171,0.953409876224205
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51868,0.000562898793967432,0.00486804277380226,-0.008978465042685,0.0101042626306199,0.907945668811022
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51816,-0.000369924511915913,0.00485562457698346,-0.00988694868280349,0.00914709965897167,0.939272794202333
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51868,-0.00382222144198002,0.00435592891347734,-0.0123598421123956,0.00471539922843556,0.380237650308184
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51868,-0.00383048098756461,0.00435693607881879,-0.0123700757020494,0.00470911372692022,0.379319234234999
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51868,-0.00381171375934474,0.00435595385745673,-0.0123493833199599,0.00472595580127044,0.38155143116875
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51868,-0.00379587098117068,0.00435606966788618,-0.0123337675302276,0.00474202556788623,0.383546030430381
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51868,-0.00380560797264527,0.00435596361514547,-0.0123432966583304,0.00473208071303985,0.382315594371326
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2405.Number of children fathered,39982,-0.0811811757808176,0.0343974762068076,-0.148600229146161,-0.0137621224154746,0.0182881507140872
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49590,0.000303335552304081,0.00506020520077605,-0.00961466664121698,0.0102213377458251,0.952199782596658
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49590,0.00236102542247888,0.00454344359699116,-0.00654412402762379,0.0112661748725815,0.603309352108595
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49590,-0.00417365742879817,0.00461719404275663,-0.0132233577526012,0.00487604289500483,0.366038922073466
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49590,-0.00274300271306495,0.00474083180015024,-0.0120350330413594,0.00654902761522953,0.562871553280788
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49590,0.00584352987098193,0.00456731226873043,-0.00310840217572971,0.0147954619176936,0.200762268671248
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49590,-0.0052898861262382,0.00465121842728203,-0.014406274243711,0.00382650199123458,0.255421277143041
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52010,-0.00343120182447833,0.00486650234627225,-0.0129695464231719,0.00610714277421528,0.48077681145765
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52010,-0.00495354710252481,0.00455140578604647,-0.0138743024431759,0.00396720823812627,0.27644973463112
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52010,0.0016122972361323,0.00429539957008912,-0.00680668592124236,0.010031280393507,0.707400383860215
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35510,-0.0101268198836451,0.0385136012192641,-0.0856134782734028,0.0653598385061127,0.792604329379944
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,38395,-0.0969923339768905,0.033246058787147,-0.162154609199699,-0.0318300587540824,0.00353806992758676
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),40827,0.018491983660858,0.0260689063022174,-0.0326030726914881,0.0695870400132042,0.478121405503633
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2734.Number of live births,41172,-0.0334371209544155,0.0252480463839144,-0.0829232918668876,0.0160490499580567,0.185413815117034
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2744.Birth weight of first child,39352,-0.017815839216554,0.0271502533316174,-0.0710303357465242,0.0353986573134162,0.51171404437799
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2754.Age at first live birth,38126,0.0249193092204403,0.00802459796346168,0.00919109721205543,0.0406475212288252,0.00190638952788722
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2764.Age at last live birth,38100,0.0176819673039811,0.00738261950113017,0.00321203308176594,0.0321519015261962,0.0166372487779687
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37034,-0.000746595051405931,0.0113051018556102,-0.0229045946884018,0.02141140458559,0.947347231879989
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36252,-0.0096965794512838,0.0084988762754902,-0.0263543769512446,0.00696121804867699,0.253939886906524
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,36182,-0.00617491710927796,0.00806234988251607,-0.0219771228790095,0.00962728866045353,0.443764377010667
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36009,-0.00420462726177604,0.0444157069737207,-0.0912594129302686,0.0828501584067165,0.924583446111424
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36005,-0.0283320872240948,0.0486577999360402,-0.123701375098734,0.067037200650544,0.560402585163002
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36021,-0.0656648791051348,0.0510793589666586,-0.165780422679786,0.034450664469516,0.198645078193537
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35996,-0.0698826968425251,0.0500789238106668,-0.168037387511432,0.0282719938263819,0.162925372183952
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36028,0.144538388161267,0.0380595390794913,0.0699416915654641,0.21913508475707,0.00014731628350048
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36050,0.138235308210336,0.0425764981718185,0.0547853717935716,0.2216852446271,0.00117291688644299
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28741.Difficulty learning a new task,35989,0.0612830724379977,0.0484474320290097,-0.0336738943388614,0.156240039214857,0.205936399497049
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35720,0.0297936836107639,0.0525112719968927,-0.0731284095031458,0.132715776724674,0.570477654345666
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36006,0.00501728168638808,0.0438582232326914,-0.0809448358496871,0.0909793992224633,0.908925877181581
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36052,0.0696292392639765,0.0682321118220173,-0.0641056999071773,0.20336417843513,0.307538731511552
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35710,-0.0216321686306923,0.0387384356097149,-0.0975595024257335,0.0542951651643489,0.576579424506751
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,36184,0.0119276651094601,0.00763333147401926,-0.00303366457961762,0.0268889947985379,0.118197479568722
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35324,-0.0441278665481353,0.0184254671199926,-0.0802417821033208,-0.00801395099294992,0.0166529740781037
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35324,0.0118103389765641,0.0207532474938278,-0.0288660261113385,0.0524867040644666,0.569320055029384
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35324,-0.00505858635259474,0.0673437106276,-0.137052259182691,0.126935086477501,0.940124913803269
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35324,0.0522590010296875,0.0787535425217072,-0.102097942312859,0.206615944372234,0.506986348846225
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35324,-0.0135864248376394,0.096231668844007,-0.202200495771893,0.175027646096614,0.887728790502328
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35324,-0.0394162335722357,0.0812088722671375,-0.198585623215825,0.119753156071354,0.627432274521654
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35324,0.0678159320050972,0.0336451667413141,0.00187140519212163,0.133760458818073,0.0438830920947559
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35324,0.0620020913132792,0.0566952311470371,-0.0491205617349136,0.173124744361472,0.274171977659606
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35278,0.00360799289571383,0.0520309183505954,-0.0983726070714532,0.105588592862881,0.944718680969689
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29003.Recent feelings of depression,35269,-0.0443497027934158,0.0501384167985023,-0.14262099971848,0.0539215941316488,0.376436917736301
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35281,-0.0330715398188716,0.039078873848173,-0.109666132561291,0.0435230529235474,0.397431689510011
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35285,0.0281597060233707,0.0390084365463705,-0.0482968296075155,0.104616241654257,0.470391315287137
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35295,-0.0448220453565112,0.0597561504197161,-0.161944100179155,0.0723000094661324,0.453233925148359
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35263,0.0421863238837831,0.0566733456593465,-0.0688934336085362,0.153266081376102,0.456677378213282
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35295,-0.00415464833409385,0.0548419384641332,-0.111644847723795,0.103335551055607,0.939615091352281
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35288,0.105034519602309,0.093559956490747,-0.0783429951195552,0.288412034324173,0.261632981717476
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35266,0.0172036526508251,0.10661581218317,-0.191763339228188,0.226170644529838,0.871814314534248
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,36297,-0.00223493889241511,0.0361584638902663,-0.073105528117337,0.0686356503325068,0.950716226036529
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36297,0.0078251361550856,0.0953080555524199,-0.178978652727658,0.194628925037829,0.934566629724442
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36297,-0.00193623742450088,0.037311931072524,-0.0750676223266479,0.0711951474776461,0.958615210758438
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36297,0.103631803103598,0.113991150240124,-0.119790851367045,0.327054457574241,0.363316851531163
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36297,-0.0648439776928795,0.09523703131995,-0.251508559079981,0.121820603694222,0.495976344068219
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36297,-0.0775691481434452,0.0984151540349091,-0.270462850051867,0.115324553764977,0.430615993127929
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36297,0.137737727095489,0.100777958742605,-0.0597870720400169,0.335262526230995,0.171748642112127
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36297,0.130748305454235,0.102057359438388,-0.0692841190450057,0.330780729953477,0.200191344527861
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36297,0.0106138678503764,0.0665568494348122,-0.119837557041855,0.141065292742608,0.873302569351592
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36297,0.00176968106252961,0.0332742199868103,-0.0634477901116187,0.0669871522366779,0.957586202019091
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36297,0.00210912669573385,0.0593224276118695,-0.11416283142353,0.118381084814998,0.971639294595572
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36297,-0.0154263465012941,0.0923015010926576,-0.196337288642903,0.165484595640315,0.867272547734836
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36297,0.115059158048186,0.137265025517952,-0.153980291967001,0.384098608063372,0.401931809557282
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36297,0.119161419894022,0.0871072846783864,-0.0515688580756152,0.289891697863659,0.171360185572603
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36297,0.0531919235733337,0.126371512154858,-0.194496240250187,0.300880087396855,0.673828392400408
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36297,-0.0340653310070883,0.12645154110504,-0.281910351572966,0.21377968955879,0.78763405686398
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36297,0.066510852749911,0.0715606078600212,-0.0737479386557306,0.206769644155553,0.352695865646354
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36297,0.0920149243773636,0.0668458433596623,-0.0390029286075745,0.223032777362302,0.168702773341189
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36297,0.0320933299978928,0.0951215507934084,-0.154344909557188,0.218531569552973,0.735830752126715
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35191,-0.0442576690510059,0.0460510389540548,-0.134517705400953,0.0460023672989415,0.336562315261056
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35204,-0.0625389398172186,0.0469945812681185,-0.154648319102731,0.0295704394682938,0.183315477581636
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35200,-0.0450789839665657,0.0437758665036993,-0.130879682313816,0.040721714380685,0.303160433884843
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29061.Recent trouble relaxing,35199,-0.0343107445629502,0.0473909268542951,-0.127196961197369,0.0585754720714682,0.469097658928784
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29062.Recent restlessness,35214,0.0838748044831068,0.0705330818421441,-0.0543700359274957,0.222119644893709,0.234425386754202
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35184,0.0589693660983993,0.0486930156466493,-0.0364689445690332,0.154407676765832,0.225926479655959
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35187,0.0271438987184031,0.0549721228944099,-0.0806014621546403,0.134889259591446,0.621482694512853
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36297,0.0403902500294205,0.0416909428995931,-0.0413239980537821,0.122104498112623,0.332677200131789
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36297,0.107755163331894,0.0733206535313089,-0.0359533175894711,0.25146364425326,0.14170283795035
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36297,0.123746548570529,0.0905293852527911,-0.0536910465249412,0.301184143666,0.171693222101619
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36297,0.149882422482127,0.0847885912829862,-0.0163032164325257,0.31606806139678,0.0771507803181363
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36297,0.162349282036206,0.0639885590465458,0.0369317063049761,0.287766857767436,0.0111967617351184
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36297,0.057680509145716,0.0683900923771803,-0.0763640719135573,0.191725090204989,0.399030677499184
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36297,0.188540634887782,0.0675781916579269,0.0560873792382453,0.320993890537319,0.005285463537446
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36297,0.176750206705553,0.0679839144679871,0.0435017343482987,0.309998679062808,0.00934486460757683
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36297,0.0941182241355729,0.0880047265455233,-0.0783710398936528,0.266607488164799,0.284895257563878
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29076.Felt loved as a child,35183,0.090373141676792,0.0406157105925868,0.0107663489153218,0.169979934438262,0.026113098602396
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29077.Physically abused by family as a child,35203,0.0679431050395334,0.0612641854492008,-0.0521346984409002,0.188020908519967,0.267466676549372
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35188,-0.029895135392212,0.0601103508914877,-0.147711423139528,0.0879211523551038,0.618969278917859
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29079.Sexually molested as a child,35145,-0.0916813480381145,0.0766172556682759,-0.241851169147935,0.0584884730717062,0.231504392026131
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35162,-0.0346174650246763,0.05600333973221,-0.144384010899808,0.0751490808504554,0.536511827979351
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35195,-0.0989731201893879,0.0880584930545828,-0.27156776657637,0.0736215261975945,0.261080278026481
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35151,-0.0715105809416951,0.0652002168448718,-0.199303005957644,0.0562818440742536,0.272779991628695
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35200,0.0221274966349021,0.0763818053056197,-0.127580841764112,0.171835835033917,0.772058886893253
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35188,-0.0273392673230395,0.104834664461816,-0.2328152096682,0.178136675022121,0.794267571733519
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35187,-0.0841871127110042,0.0964800746605077,-0.273288059045599,0.104913833623591,0.382924019194572
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35202,-0.042882563616655,0.0934928214852949,-0.226128493727833,0.140363366494523,0.646486132185655
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35195,0.146540519573938,0.0457446707821915,0.0568809648408431,0.236200074307034,0.00136504127172527
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35202,-0.14168877318316,0.045909947707007,-0.231672270688894,-0.0517052756774261,0.00203633070334837
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35210,-0.0197568171007036,0.0488713289082323,-0.115544621760839,0.0760309875594318,0.686034500087668
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35200,0.00456501180773342,0.0586587332914413,-0.110406105443491,0.119536129058958,0.937971264311663
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35199,-0.263745812708272,0.0365016375960088,-0.335289022396449,-0.192202603020095,5.60963494121333e-13
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34453,-0.364786525030808,0.0465935705282498,-0.456109923266178,-0.273463126795439,5.90017720178292e-15
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34476,-0.420389511362831,0.0481821699724624,-0.514826564508857,-0.325952458216805,3.51816028557517e-18
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29104.Ever used cannabis,35200,-0.0416029260493198,0.0694908990727381,-0.177805088231887,0.0945992361332469,0.549407785920006
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35167,-0.0323003895032916,0.0502414010055991,-0.130773535474266,0.0661727564676826,0.520311181423201
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35191,0.0405004638543583,0.075937726421002,-0.108337479930806,0.189338407639522,0.593819498003145
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29111.Ever self-harmed,35199,0.040586841172731,0.133567044518942,-0.221204566084396,0.302378248429858,0.761238471671229
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35189,0.019414800896738,0.0749094005994299,-0.127407624278145,0.166237226071621,0.795507502530381
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36935,0.0351848714924024,0.0983937525223871,-0.157666883451476,0.228036626436281,0.720658013773452
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36935,-0.0213350665810265,0.0727854276157635,-0.163994504707923,0.12132437154587,0.769436165577106
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36935,0.082536043422127,0.0855736618669714,-0.085188333837137,0.250260420681391,0.334823993665595
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36935,0.134306771733997,0.124121722140128,-0.108971803660654,0.377585347128648,0.279260930080851
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35180,-0.0230797780152994,0.0422877460648011,-0.10596376030231,0.0598042042717107,0.585237969389019
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35191,-0.0149777111832265,0.0383547712151181,-0.090153062764858,0.060197640398405,0.696177397445389
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29154.Anxiety or depression today,35191,0.00417977154079436,0.0501250990725911,-0.0940654226414841,0.102424965723073,0.933546769673808
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35012,0.040321883229279,0.0378977813738072,-0.033957768263383,0.114601534721941,0.287389097040331
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35173,0.00624494263567047,0.0179342163374007,-0.0289061213856349,0.0413960066569758,0.727691841348657
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35173,-0.0250741079913094,0.0183197751134366,-0.0609808672136453,0.0108326512310264,0.171147362161703
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35173,-0.111250901814203,0.0228830547571266,-0.156101689138171,-0.066400114490235,1.19347440638685e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35173,0.0768212163283092,0.0211902126659664,0.035288399503015,0.118354033153603,0.000291009250543461
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35173,0.054713693956814,0.0362771587087513,-0.0163895371123386,0.125816925025967,0.131552774969917
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35173,0.0368577857383159,0.0173217542873064,0.00290714733519533,0.0708084241414364,0.0333917986021229
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35170,-0.0183140414607406,0.0185784350663109,-0.05472777419071,0.0180996912692288,0.324286492651356
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35170,0.00340725777706585,0.0285227367336875,-0.0524973062209616,0.0593118217750933,0.904916842319681
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35170,-0.0877946652486943,0.0416892931308214,-0.169505679785104,-0.0060836507122843,0.0352521780362265
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35170,0.0859377694058874,0.0331554534313923,0.0209530806803586,0.150922458131416,0.00956617889112683
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35170,0.0367208167734252,0.0559241272388106,-0.0728904726146434,0.146332106161494,0.51145153089461
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35170,0.0152910231133904,0.0252834308789957,-0.0342645014094412,0.0648465476362219,0.545345260618333
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35070,-0.0461373970079534,0.049387556464569,-0.142937007678509,0.0506622136626018,0.350243914204968
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35152,-0.00297071726615115,0.0438378144374572,-0.0888928335635673,0.082951399031265,0.945974112474102
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29173.Frequency of feeling left out,35110,0.0306349322383477,0.0469103810379819,-0.0613094145960969,0.122579279072792,0.513747943500045
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35144,0.0634159216490431,0.0487207902045447,-0.0320768271518645,0.158908670449951,0.193096954171917
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35186,-0.041996808629616,0.0391150888903458,-0.118662382854694,0.0346687655954616,0.283012594725027
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35186,0.0993431755055122,0.0373585564116081,0.0261204049387604,0.172565946072264,0.00785392254559861
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35186,-0.00259945489676136,0.0385099222135881,-0.078078902435394,0.0728799926418712,0.946185188728181
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35186,0.00458837382970761,0.0373700287058568,-0.0686568824337717,0.0778336300931869,0.902283700527945
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35186,-0.0345172050120367,0.0383840463761394,-0.10974993590927,0.0407155258851965,0.368550793025557
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35186,0.05956929112277,0.0379585274964921,-0.0148294227703544,0.133968005015894,0.116624905035054
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29181.General happiness,35158,0.013246217429048,0.0395250177097866,-0.0642228172821338,0.0907152521402298,0.737535034555969
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35069,-0.0129362214724451,0.0392481202941351,-0.0898625372489499,0.0639900943040598,0.741713189042616
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35522,0.00524726801216533,0.036163072553497,-0.0656323541926888,0.0761268902170194,0.884636404409438
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2946.Father's age,30155,0.0577847249150147,0.0420264456949104,-0.0245871086470098,0.140156558477039,0.169463999604577
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,36736,-0.0185120026605546,0.00821060457969764,-0.034604787636762,-0.00241921768434727,0.0241841545636742
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51419,0.0213092903987285,0.00470035023226289,0.0120966039434932,0.0305219768539638,5.83020544650341e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51420,-0.0689149467321393,0.00493333561502067,-0.0785842845375798,-0.0592456089266988,3.69285213112375e-44
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51420,-0.0840270166856394,0.00529314645400584,-0.0944015837354908,-0.073652449635788,1.93896996000119e-56
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51420,-0.0724334955905531,0.00515858001598686,-0.0825443124218873,-0.0623226787592188,1.34995056212372e-44
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51420,0.012389890286002,0.00454587387509183,0.00347997749082197,0.0212998030811819,0.00642496857940824
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51420,0.00108626361502124,0.00455947627811964,-0.00785030989009325,0.0100228371201357,0.811694771784238
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51420,-0.0226729713329667,0.00445239435696804,-0.031399664272624,-0.0139462783933093,3.56615893713926e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51420,0.0584393435282043,0.00458539661189348,0.0494519661688931,0.0674267208875155,4.50136397466588e-37
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30080.Platelet count,51420,-0.0232979710734802,0.00450935639213237,-0.0321363096020596,-0.0144596325449007,2.40469527988965e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30090.Platelet crit,51420,-0.00589049822423879,0.00459191451597612,-0.014890650675552,0.00310965422707441,0.199576272731538
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51420,0.0352508259535271,0.00428254219688197,0.0268570432476385,0.0436446086594158,1.95305057229202e-16
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51420,-0.00493019505265999,0.00445165814965307,-0.01365544502598,0.00379505492066004,0.26809138440072
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51382,-0.0149178049593753,0.00442324977259713,-0.0235873745136657,-0.00624823540508493,0.000745921511764083
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30130.Monocyte count,51382,0.0484139458609912,0.00452488226387837,0.0395451766237896,0.0572827150981928,1.18865035137696e-26
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51382,0.0225664870122454,0.00465528566871503,0.013442127101564,0.0316908469229269,1.25873701959337e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51382,0.0307963612506017,0.00444416317375538,0.0220858014300412,0.0395069210711623,4.33528078287693e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30160.Basophill count,51382,0.0451920133345639,0.0211728379635804,0.00369325092594637,0.0866907757431813,0.0328182449881267
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51382,0.274052912414764,0.105682506085889,0.0669152004864209,0.481190624343107,0.00951576280360225
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51383,-0.0341395496449253,0.00440383418505368,-0.0427710646476305,-0.02550803464222,9.41596703459809e-15
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51383,0.0379231524578711,0.00446604318884452,0.0291697078077358,0.0466765971080063,2.16720081748689e-17
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51383,0.0136897532060205,0.00437641850382591,0.00511197293852171,0.0222675334735193,0.00176184567592776
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51383,0.024977143237606,0.00440927421762965,0.0163349657710519,0.0336193207041601,1.49119566150157e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51383,0.00131973494744616,0.00439588653184674,-0.00729620265497344,0.00993567254986576,0.764011834560565
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51382,0.273881546209665,0.105676884398343,0.0667548527889127,0.481008239630416,0.00955688192528914
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51042,-0.0705569297317712,0.00473522282566776,-0.07983796647008,-0.0612758929934624,5.76203897084369e-50
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51042,-0.0855318994210836,0.00481139331372231,-0.0949622303159793,-0.0761015685261879,3.33068201266664e-70
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51042,0.0279814690030837,0.00445298894690484,0.0192536106671503,0.0367093273390172,3.36744836298737e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51042,0.0282212569620188,0.00450999695191151,0.0193816629362722,0.0370608509877653,3.98493594001077e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51042,-0.0174140414508027,0.00469439393797632,-0.0266150535692363,-0.00821302933236907,0.000208150497238131
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51042,-0.0634642157584676,0.00483330107946988,-0.0729374858742286,-0.0539909456427067,3.09604638871205e-39
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51042,-0.0755660936088059,0.00489137859569009,-0.0851531956563585,-0.0659789915612534,1.47523563338528e-53
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,37095,0.0139811443719316,0.0075259528054608,-0.000769723126771612,0.0287320118706347,0.0632453707936797
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51395,0.0172262643608733,0.0049154534156549,0.00759197566618965,0.0268605530555569,0.000458346377848801
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51358,-0.0239867059245453,0.00460731407441134,-0.0330170415103916,-0.0149563703386991,1.94442167421291e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51338,-0.00295258030347985,0.00485575906404488,-0.0124698680690078,0.00656470746204811,0.543155631067232
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30600.Albumin,49182,-0.0720153828660119,0.00474589550775405,-0.0813173380612099,-0.062713427670814,1.01723410992523e-51
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50998,0.0532963409530108,0.00469145594374449,0.0441010873032716,0.0624915946027501,7.99645275612211e-30
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51002,-0.0190595791521736,0.00500669141759579,-0.0288726943306614,-0.00924646397368586,0.000141149426090928
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49040,-0.0360928438095118,0.00522036199101988,-0.0463247533119108,-0.0258609343071129,4.85975480561573e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50899,-0.200986321085031,0.00414540484369211,-0.209111314578668,-0.192861327591395,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50940,0.0268857737087502,0.00478173072153289,0.0175135814945457,0.0362579659229547,1.90409392417522e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,47812,-0.0369697589270446,0.00502478792767537,-0.0468183432652883,-0.0271211745888009,1.95207074934421e-13
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30670.Urea,50985,0.0932200471945054,0.00457589629014917,0.084251290465813,0.102188803923198,2.10628851112429e-91
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30680.Calcium,49182,-0.0463505669037429,0.00460616048624118,-0.0553786414567757,-0.0373224923507102,9.19619532854227e-24
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30690.Cholesterol,51004,-0.172088424712037,0.00425357699926344,-0.180425435630593,-0.16375141379348,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30700.Creatinine,50995,0.088642040663897,0.00509023000314177,0.0786651898577391,0.0986188914700548,1.84464462865513e-67
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50943,-0.018263466454509,0.0050062580555097,-0.028075732243308,-0.00845120066570999,0.000264776067279608
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30720.Cystatin C,51010,0.0524587223305119,0.00506948583144525,0.0425225301008792,0.0623949145601446,4.88621607369962e-25
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50999,-0.0735390129458192,0.00501985637825017,-0.0833779314471895,-0.0637000944444488,2.30028202544275e-48
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30740.Glucose,49166,-0.00757342117350763,0.00473327564820322,-0.0168506414439859,0.00170379909697067,0.109605958048863
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50967,0.0403735232678446,0.00482964553171727,0.0309074180256787,0.0498396285100105,6.67034722209808e-17
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49173,0.00431591779546904,0.00535695453586976,-0.00618371309483568,0.0148155486857738,0.420444868455811
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30770.IGF-1,50875,0.0127312979804251,0.00458896813700872,0.00373692043188797,0.0217256755289621,0.00553633750298096
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30780.LDL direct,50954,-0.181148076181078,0.00414662878576043,-0.189275468601169,-0.173020683760988,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46577,0.0260181103141794,0.00493890162532231,0.0163378631285477,0.0356983574998111,1.39565914820262e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30810.Phosphate,49142,0.0452470647597132,0.00493583904154532,0.0355728202382844,0.0549213092811421,5.3212471573329e-20
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30830.SHBG,49011,0.0973920962676043,0.00568853864890478,0.086242560515751,0.108541632019458,3.06194396559976e-65
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50917,-0.132059830761163,0.00476616570297006,-0.141401515538984,-0.122718145983342,4.32647106553239e-166
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30850.Testosterone,48452,-0.0317557510011118,0.00765487925368573,-0.0467593143383359,-0.0167521876638878,3.36195236756802e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30860.Total protein,49164,-0.0595214880338625,0.00461743832546763,-0.0685716671517791,-0.050471308915946,7.20152946650981e-38
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30870.Triglycerides,50990,-0.106572322513615,0.00498718591634936,-0.116347206909659,-0.0967974381175698,2.76164376912533e-100
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30880.Urate,50974,-0.0588270814825775,0.00540397681462441,-0.0694188760392413,-0.0482352869259136,1.5845685823638e-27
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30890.Vitamin D,49895,0.0182678636701428,0.00507142934621524,0.00832786215156093,0.0282078651887247,0.000316379523531854
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3137.Number of measurements made,49565,0.0161658624465079,0.0249737935019397,-0.0327827728172939,0.0651144977103096,0.51743665164226
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3143.Ankle spacing width,42159,0.000958550490310041,0.00763814549470344,-0.0140122146793087,0.0159293156599288,0.900133481642627
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42158,-0.0194947540870649,0.00593504767071661,-0.0311274475216694,-0.00786206065246031,0.00102367719387093
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3146.Speed of sound through heel,42159,-0.0257793067620425,0.00568922194098607,-0.0369301817663752,-0.0146284317577098,5.91587856740099e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42159,-0.0240429034940056,0.00575777260185945,-0.0353281377936502,-0.0127576691943611,2.98973916331845e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),42147,-0.0240084083634937,0.00576718140463016,-0.0353120839165688,-0.0127047328104186,3.16213155241188e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3526.Mother's age at death,48183,0.00554608623458192,0.00461694657772258,-0.00350312905775434,0.0145953015269182,0.229670972409903
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),38436,-0.00201000226072695,0.00650859571380255,-0.01476684985978,0.010746845338326,0.757463342112336
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32776,-0.00803466326670812,0.00976126117085382,-0.0271667351615816,0.0110974086281654,0.410496067074242
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36692,-0.0175139819574984,0.0104882990055102,-0.0380710480082985,0.0030430840933017,0.0949889778406593
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36689,-0.00169451465121877,0.00815266189555928,-0.017673731966515,0.0142847026640774,0.835353282179488
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36692,-0.0151342193064506,0.00780564276604909,-0.0304332791279068,0.000164840515005581,0.052553197205704
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36692,-0.0112450583636582,0.00790461801551925,-0.026738109674076,0.00424799294675953,0.154895623799263
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36687,-0.0119271065936665,0.00790668232964828,-0.0274242039597772,0.00356999077244408,0.131472768852205
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36692,-0.0112377253356074,0.00790458282433021,-0.0267307076712946,0.00425525700007981,0.155163037426665
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36694,-0.0135156877404735,0.0103319265651988,-0.0337662638082632,0.0067348883273162,0.19086324924029
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36693,-0.00815434490626472,0.00812790304664435,-0.0240850348776876,0.00777634506515822,0.315771071354282
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36694,-0.0191505346008031,0.00776149015076078,-0.0343630552962942,-0.00393801390531194,0.0136328048199056
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36694,-0.0162567699574336,0.00786507040889245,-0.0316723079588628,-0.000841231956004419,0.0387723494448954
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36689,-0.016536296546989,0.00786137220230597,-0.0319445860635087,-0.00112800703046929,0.0354564348146549
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36694,-0.016255532376308,0.00786507270909198,-0.0316710748861282,-0.00083998986648768,0.0387872413967578
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4194.Pulse rate,37045,0.0367079370533746,0.00746366379220063,0.0220791560206614,0.0513367180860879,8.91088032068389e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4195.Pulse wave reflection index,37045,-0.0319805427779356,0.00807607448889033,-0.0478096487761607,-0.0161514367797106,7.56398820430003e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,37039,0.0126878765858386,0.00736148978708142,-0.00174064339684097,0.0271163965685182,0.0848289820707273
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,37045,-0.0245977139290359,0.00787929447151875,-0.0400411310932127,-0.00915429676485916,0.00180391542528491
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4199.Position of pulse wave notch,37045,0.0295851211988631,0.00753906440022277,0.0148085549744265,0.0443616874232997,8.77456078213573e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,37045,-0.00771482610687811,0.00776119640541667,-0.0229267710614948,0.00749711884773856,0.320241152418202
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),36853,-0.100663040301362,0.094775839471111,-0.28642368566474,0.0850976050620154,0.288216075183606
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36763,-0.00114103178005923,0.0318613146670622,-0.0635892085275011,0.0613071449673826,0.97143284948408
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),36854,-0.048110162621381,0.0922675094629576,-0.228954481168778,0.132734155926016,0.602089036365366
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36763,0.0361284207398329,0.031573492075259,-0.0257556237276747,0.0980124652073406,0.252550230384007
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4288.Time to answer,37047,-0.0103148255992937,0.00881138148693624,-0.0275851333136887,0.00695548211510134,0.241784967464364
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4290.Duration screen displayed,37047,-0.000187430649140239,0.00835815256610192,-0.0165694096787,0.0161945483804195,0.982109595996782
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X46.Hand grip strength (left),52007,-0.0420389580793762,0.00633128519424623,-0.0544482770600988,-0.0296296390986536,3.2100095800958e-11
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X47.Hand grip strength (right),52035,-0.0484131836460476,0.00628038942166361,-0.0607227469125082,-0.0361036203795869,1.32351025070781e-14
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X48.Waist circumference,52096,-0.0871250084509023,0.00957145607422453,-0.105885062356382,-0.0683649545454222,9.52235904335651e-20
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X4803.Tinnitus,36950,0.0418997723972557,0.0358585629605195,-0.0283830110053626,0.112182555799874,0.242651841900536
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4825.Noisy workplace,37027,0.0336512311262868,0.0417649023369728,-0.0482079774541799,0.115510439706754,0.420423062587692
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,36985,-0.0616498983294256,0.0691103357989542,-0.197106156495376,0.0738063598365247,0.372393509129629
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X49.Hip circumference,52091,0.0010985216286958,0.00782010907692835,-0.0142288921620838,0.0164259354194754,0.888286767192357
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X50.Standing height,52071,-0.0158709679611292,0.00621228467944236,-0.0280470459328362,-0.00369488998942219,0.010632167298467
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X5057.Number of older siblings,35819,0.0369939401302981,0.0347256481556455,-0.0310683302547672,0.105056210515363,0.286769809922256
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X51.Seated height,51982,-0.0175381404287103,0.00580030234661934,-0.0289067330280842,-0.0061695478293364,0.00250014968884475
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5181.Ever had eye surgery,34463,-0.0533351086746838,0.0704031766755804,-0.191325334958821,0.0846551176094538,0.448744257236505
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34448,-0.00640354405570744,0.0090999630794985,-0.0242394716915245,0.0114323835801096,0.481657646072216
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34448,-0.0146644872754201,0.00933966293239413,-0.0329702266229126,0.00364125207207242,0.116445029932032
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),34375,-0.0146033207563032,0.00958876887289256,-0.0333973077471726,0.00419066623456622,0.127829500616491
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),34374,-0.01093842908917,0.00967683108253056,-0.0299050180109299,0.00802815983258988,0.258371399542314
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",34431,-0.0280726159283275,0.0407370267326501,-0.107917188324322,0.0517719564676667,0.490779586424861
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),34431,-0.328384488136879,0.242662817226792,-0.804003609901391,0.147234633627634,0.176032851576856
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5201.logMAR, final (right)",34375,0.00878774220202207,0.0100492660358314,-0.0109088192282076,0.0284843036322517,0.38190502183347
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5202.Number of rounds to result (right),34431,-0.0813871667144816,0.0369156695115506,-0.153741878957121,-0.0090324544718425,0.0275201067480039
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",34430,0.0494721238839653,0.0406920495301536,-0.0302842931951357,0.129228540963066,0.224127831261112
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),34430,-0.627237175896946,0.222016507400868,-1.06238953040265,-0.192084821391244,0.00474325946814094
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5208.logMAR, final (left)",34369,0.0104391532507171,0.0100241802694212,-0.00920824007734837,0.0300865465787827,0.297739890760159
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5209.Number of rounds to result (left),34428,-0.0384160643873789,0.0370996159152202,-0.111131311581211,0.0342991828064528,0.300490802012988
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34175,-0.0212444111190967,0.00938719393316057,-0.0396433112280914,-0.00284551101010197,0.023670731235444
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34175,-0.0343726749030487,0.00947944082827458,-0.0529523789264669,-0.0157929708796305,0.000290696939898066
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),34175,-0.0103370618192945,0.00947102863569859,-0.0289002779452638,0.0082261543066747,0.275132002185953
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),34175,-0.0274693670437295,0.00954783171095902,-0.0461831171972092,-0.00875561689024985,0.00403147670364004
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34168,-0.0371889670122696,0.00933164241604397,-0.0554789861477158,-0.0188989478768234,6.83727864012759e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34168,-0.0405816159480798,0.0093958159509393,-0.0589974152119209,-0.0221658166842388,1.59705953165158e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),34168,0.00466276709006144,0.00958046895464183,-0.0141149520610366,0.0234404862411594,0.626495877458439
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),34168,-0.017856297278929,0.00959528089004274,-0.0366630478234128,0.000950453265554756,0.0628107967098704
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34573,0.116250802161319,0.206875453603217,-0.289225086900985,0.521726691223624,0.57418291979099
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52038,0.0142200693224233,0.0236405934153328,-0.0321154937716291,0.0605556324164756,0.547505872277867
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52038,0.00551677068675908,0.0249947672969942,-0.0434729732153495,0.0545065145888676,0.825314746588029
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52038,0.0117201306679271,0.066005463139136,-0.11765057708478,0.141090838420634,0.859067727621069
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52038,0.0197678828214778,0.0100940028202775,-1.63627062660029e-05,0.0395521283492216,0.0501977120032931
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52038,-0.0271077638195981,0.00950222794178893,-0.0457321305855044,-0.00848339705369178,0.00433775575985073
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38244,-0.0301804704163607,0.0136956081162564,-0.0570238623242233,-0.00333707850849811,0.027573322682667
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38244,0.00247002108368715,0.0293736044015739,-0.0551022435433978,0.0600422857107721,0.932986878984885
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38244,0.0137100367692741,0.0358624361727204,-0.056580338129258,0.0840004116678061,0.702251400693941
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38244,-0.0172190895846912,0.0194419037188266,-0.0553252208735913,0.020887041704209,0.375819500583173
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52109,-0.0289034896128039,0.0196681398855563,-0.0674530437884941,0.00964606456288638,0.14169499260185
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52109,-0.0289034896128039,0.0196681398855563,-0.0674530437884941,0.00964606456288638,0.14169499260185
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52109,-0.0209689818032246,0.0158056392109564,-0.0519480346566992,0.01001007105025,0.184628693469192
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52109,0.0453395621159655,0.0272983506770502,-0.00816520521105301,0.098844329442984,0.0967491888812812
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52109,0.0562146923368085,0.0655112233988041,-0.0721873055248475,0.184616690198464,0.390850339103701
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52109,0.0180770169545888,0.0450720179767372,-0.070264138279816,0.106418172188994,0.688372609577545
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52109,0.0894648603785157,0.0737559789045721,-0.0550968582744457,0.234026579031477,0.225148244422283
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52038,0.0115241134381743,0.0146534978984557,-0.0171967424427988,0.0402449693191474,0.431617253552301
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52038,0.0756759100290127,0.0246589781845251,0.0273443127873435,0.124007507270682,0.002151010227187
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52038,-0.00120559987721083,0.0146157930346431,-0.0298525542251114,0.0274413544706897,0.93426088789262
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52038,0.025540531559292,0.0206256288840102,-0.0148857010533681,0.065966764171952,0.215620887760561
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52038,0.00363528878005956,0.0251744250826272,-0.0457065843818897,0.0529771619420088,0.885182697712121
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52038,0.00669474527248189,0.009767101795118,-0.0124487742459494,0.0258382647909132,0.493074362323639
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38783,0.125953133057177,0.0221846211764545,0.0824712755513263,0.169434990563028,1.40656975790216e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38783,0.0711918550231643,0.0190293939950968,0.0338942427927746,0.108489467253554,0.000184247036118593
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38783,0.156778466336763,0.0273814993079057,0.103110727693268,0.210446204980259,1.0610235247216e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38783,-0.08971654878317,0.0215245769703209,-0.131904719644999,-0.047528377921341,3.09850123833217e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52026,0.017649775017433,0.0334612579711852,-0.04793429060609,0.0832338406409561,0.597873089975246
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52026,0.0343181331245597,0.0507666572161385,-0.0651845150190717,0.133820781268191,0.499049082259479
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52026,0.175903946917936,0.0798867289887661,0.0193259580999547,0.332481935735918,0.0276811342619496
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52026,0.111401131781781,0.085146976037695,-0.0554869412521011,0.278289204815663,0.190771434262165
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52026,0.00752097307689122,0.0276260107138903,-0.0466260079223338,0.0616679540761163,0.785438058822266
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52026,0.0637886525698126,0.0384453939371845,-0.0115643195470689,0.139141624686694,0.0970889441449917
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52026,-0.00620303254412921,0.0202004466420161,-0.0457959079624808,0.0333898428742223,0.758789825445942
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35963,0.021019313771659,0.0268278089090674,-0.031563191690113,0.0736018192334311,0.433366972215491
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35963,0.0137409890431412,0.0281786214947129,-0.041489109086496,0.0689710871727784,0.625821503664281
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35963,0.0479872918741928,0.0389860607077575,-0.0284253871130119,0.124399970861398,0.21840927389395
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35963,0.00208074074068259,0.0164191024123562,-0.0301006999875356,0.0342621814689008,0.899160376620758
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40477,0.0817918106409239,0.0128738372856132,0.0565590895611221,0.107024531720726,2.18808033139583e-10
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40477,-0.060617809349063,0.0152378795332325,-0.0904840532341986,-0.0307515654639274,6.99022874522822e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40477,-0.0156475927166168,0.0126145474633264,-0.0403721057447366,0.00907692031150298,0.214838385687289
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40477,-0.030198821629806,0.0289851133879702,-0.0870096438702276,0.0266120006106156,0.297492653430818
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40477,0.0064930260843236,0.016139372452156,-0.0251401439219021,0.0381261960905493,0.687463738107904
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40477,0.0519092073309776,0.0230871356726129,0.00665842141265625,0.0971599932492989,0.0245696632964159
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52038,0.0317353019413527,0.0274621662331096,-0.022090543875542,0.0855611477582475,0.247856556921774
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52038,0.0192753539477371,0.0206896093027501,-0.0212762802856531,0.0598269881811273,0.351530292281893
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52038,0.0682864802125157,0.0524625334189725,-0.0345400852886703,0.171113045713702,0.193058157924072
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52038,0.0431449992984509,0.0192904239110128,0.00533576843286576,0.0809542301640359,0.0253219802925583
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52038,-0.0208660063177114,0.0228253006101802,-0.0656035955136645,0.0238715828782418,0.360641748103035
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52038,0.0721693027875519,0.0273130285307109,0.0186357668673586,0.125702838707745,0.0082400431613398
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52038,-0.0054387452265626,0.00912940965523805,-0.0233323881508292,0.012454897697704,0.551355513269162
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34858,0.0795647742564744,0.0231893555525351,0.0341136373735057,0.125015911139443,0.000605455779219826
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34858,0.0754678416013962,0.0284384146456578,0.0197285488959068,0.131207134306886,0.00798300810370232
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34858,-0.0542121251561809,0.019900930812908,-0.0932179495494806,-0.0152063007628811,0.00646747581854847
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34858,-0.0278188699748153,0.0186644436520011,-0.0644011795327374,0.00876343958310682,0.136155294022697
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52133,0.0315094177733291,0.0121829480014705,0.00763083969044689,0.0553879958562113,0.00970582271848975
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52133,0.0197734060911024,0.0339610581943219,-0.0467902679697684,0.0863370801519733,0.56041235109653
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52133,0.0035125242256754,0.0101423566817825,-0.0163664948706182,0.023391543321969,0.729103692796478
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52133,0.020762128522392,0.00976567358184541,0.00162140830197504,0.039902848742809,0.0335112957738641
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52133,0.0321829992548384,0.0166561727620011,-0.000463099358683661,0.0648290978683605,0.0533475512002714
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52133,0.0106283503951304,0.012478400111237,-0.0138293138228942,0.0350860146131549,0.394367400115796
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52133,-0.0334990074846726,0.010214182604575,-0.0535188053896395,-0.0134792095797057,0.0010408850570817
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52133,0.0646895060708919,0.0311607984955694,0.00361434101957582,0.125764671122208,0.0379059872905817
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45493,-0.0245828748533176,0.0106610316289442,-0.0454784968460483,-0.00368725286058686,0.0211307961838914
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45493,-0.105378351695588,0.0110438193462482,-0.127024237614234,-0.0837324657769411,1.59713089018411e-21
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45493,0.0961316938619158,0.0117010414462946,0.0731976526271785,0.119065735096653,2.26707349667737e-16
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45493,0.0445102865528505,0.0160208926373683,0.0131093369836086,0.0759112361220925,0.0054712525932231
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45493,0.0373357713659768,0.0106976989349277,0.0163682814535186,0.058303261278435,0.00048416108928792
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51902,-0.0157040473201931,0.0107094495105843,-0.0366945683609384,0.00528647372055214,0.142560552435463
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51902,-0.00601594188409325,0.0086870745986364,-0.0230426080974206,0.0110107243292341,0.488620153398126
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51902,0.0234892691128738,0.00898838649622806,0.00587203158026678,0.0411065066454808,0.0089734041213832
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51902,-0.0195084706790091,0.0195449965385191,-0.0578166638945066,0.0187997225364883,0.31822638261969
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51921,-0.0246395813024411,0.00966169279737827,-0.0435764991853025,-0.00570266341957965,0.0107715526084814
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51921,-0.0173116451380438,0.0191514255544955,-0.054848439224855,0.0202251489487674,0.366039414648085
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52038,-0.00257290848634455,0.00881724791811481,-0.0198547144058496,0.0147088974331605,0.770439112589284
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52038,0.00665305147754045,0.0101103053736949,-0.0131631470549015,0.0264692500099824,0.510514856795881
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52038,0.0722021093041784,0.0152908728239457,0.0422319985692448,0.102172220039112,2.35027763119498e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52038,0.0118614598101273,0.0210357384428389,-0.029368587537837,0.0530915071580916,0.572846914837271
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52038,0.0937248332704554,0.0267316323709789,0.0413308338233367,0.146118832717574,0.000455528622083201
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52038,0.000554124437009491,0.0253789909229878,-0.0491886977720466,0.0502969466460656,0.982580577433702
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42159,-0.0240404460207989,0.00575774287026899,-0.0353256220465262,-0.0127552699950717,2.99505947883117e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51539,-0.0543627888274243,0.0193222858402409,-0.0922344690742965,-0.0164911085805521,0.00490518336856243
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X874.Duration of walks,48457,-0.00713563485506299,0.00482480064968998,-0.0165922441284553,0.00232097441832938,0.139170255504221
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50605,-0.0663567199999661,0.0186971005837478,-0.103003037144112,-0.0297104028558204,0.000387469373864383
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X894.Duration of moderate activity,45794,-0.0256674617166248,0.0229168694626035,-0.0705845258633277,0.019249602430078,0.262719407179334
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33447,-0.00864228306226573,0.0114544590507445,-0.0310930228017249,0.0138084566771935,0.450596388679075
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50517,-0.0653928284914134,0.019249536612777,-0.103121920252456,-0.0276637367303704,0.000682255420405624
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X914.Duration of vigorous activity,40294,0.00191107454534177,0.00593034607565797,-0.00971240376294784,0.0135345528536314,0.747266755943767
